id	sid	tid	token	lemma	pos
ajmpe-262	1	1	american	american	PROPN
ajmpe-262	1	2	journal	journal	PROPN
ajmpe-262	1	3	of	of	ADP
ajmpe-262	1	4	medical	medical	ADJ
ajmpe-262	1	5	and	and	CCONJ
ajmpe-262	1	6	physical	physical	ADJ
ajmpe-262	1	7	education	education	NOUN
ajmpe-262	1	8	vol.10	vol.10	NOUN
ajmpe-262	1	9	,	,	PUNCT
ajmpe-262	1	10	issue	issue	NOUN
ajmpe-262	1	11	4	4	NUM
ajmpe-262	1	12	;	;	PUNCT
ajmpe-262	1	13	july	july	PROPN
ajmpe-262	1	14	-	-	PUNCT
ajmpe-262	1	15	august	august	PROPN
ajmpe-262	1	16	2025	2025	NUM
ajmpe-262	1	17	;	;	PUNCT
ajmpe-262	1	18	issn	issn	PROPN
ajmpe-262	1	19	:	:	PUNCT
ajmpe-262	1	20	2994	2994	NUM
ajmpe-262	1	21	-	-	SYM
ajmpe-262	1	22	0524	0524	NUM
ajmpe-262	1	23	impact	impact	NOUN
ajmpe-262	1	24	factor	factor	NOUN
ajmpe-262	1	25	:	:	PUNCT
ajmpe-262	1	26	7.06	7.06	NUM
ajmpe-262	1	27	1252	1252	NUM
ajmpe-262	1	28	columbia	columbia	PROPN
ajmpe-262	1	29	rd	rd	PROPN
ajmpe-262	1	30	nw	nw	PROPN
ajmpe-262	1	31	,	,	PUNCT
ajmpe-262	1	32	washington	washington	PROPN
ajmpe-262	1	33	dc	dc	PROPN
ajmpe-262	1	34	,	,	PUNCT
ajmpe-262	1	35	united	united	PROPN
ajmpe-262	1	36	states	states	PROPN
ajmpe-262	1	37	https://topjournals.org/index.php/	https://topjournals.org/index.php/	PROPN
ajmpe-262	1	38	ajmpe	ajmpe	NOUN
ajmpe-262	1	39	;	;	PUNCT
ajmpe-262	1	40	mail	mail	NOUN
ajmpe-262	1	41	:	:	PUNCT
ajmpe-262	1	42	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-262	1	43	1	1	NUM
ajmpe-262	2	1	|	|	ADV
ajmpe-262	2	2	a	a	DET
ajmpe-262	2	3	m	m	NOUN
ajmpe-262	2	4	e	e	NOUN
ajmpe-262	2	5	r	r	NOUN
ajmpe-262	3	1	i	i	NOUN
ajmpe-262	3	2	c	c	VERB
ajmpe-262	3	3	a	a	DET
ajmpe-262	3	4	n	n	NOUN
ajmpe-262	4	1	j	j	NOUN
ajmpe-262	4	2	o	o	X
ajmpe-262	4	3	u	u	NOUN
ajmpe-262	4	4	r	r	NOUN
ajmpe-262	4	5	n	n	NOUN
ajmpe-262	4	6	a	a	DET
ajmpe-262	4	7	l	l	NOUN
ajmpe-262	4	8	o	o	X
ajmpe-262	5	1	f	f	X
ajmpe-262	5	2	m	m	NOUN
ajmpe-262	5	3	e	e	NOUN
ajmpe-262	6	1	d	d	NOUN
ajmpe-262	6	2	i	i	PRON
ajmpe-262	6	3	c	c	VERB
ajmpe-262	6	4	a	a	DET
ajmpe-262	6	5	l	l	NOUN
ajmpe-262	6	6	a	a	X
ajmpe-262	6	7	n	n	NOUN
ajmpe-262	7	1	d	d	NOUN
ajmpe-262	7	2	p	p	NOUN
ajmpe-262	7	3	h	h	NOUN
ajmpe-262	7	4	y	y	NOUN
ajmpe-262	7	5	s	s	VERB
ajmpe-262	8	1	i	i	INTJ
ajmpe-262	8	2	c	c	VERB
ajmpe-262	8	3	a	a	DET
ajmpe-262	8	4	l	l	NOUN
ajmpe-262	8	5	e	e	NOUN
ajmpe-262	8	6	d	d	X
ajmpe-262	8	7	u	u	X
ajmpe-262	8	8	c	c	PROPN
ajmpe-262	9	1	a	a	DET
ajmpe-262	9	2	t	t	NOUN
ajmpe-262	10	1	i	i	PRON
ajmpe-262	10	2	o	o	VERB
ajmpe-262	11	1	n	n	CCONJ
ajmpe-262	11	2	|	|	ADV
ajmpe-262	11	3	https://topjournals.org/index.php/	https://topjournals.org/index.php/	INTJ
ajmpe-262	12	1	ajmpe	ajmpe	ADJ
ajmpe-262	12	2	prevalence	prevalence	NOUN
ajmpe-262	12	3	of	of	ADP
ajmpe-262	12	4	hepatitis	hepatitis	PROPN
ajmpe-262	12	5	b	b	PROPN
ajmpe-262	12	6	surface	surface	NOUN
ajmpe-262	12	7	antigen	antigen	ADV
ajmpe-262	12	8	among	among	ADP
ajmpe-262	12	9	students	student	NOUN
ajmpe-262	12	10	of	of	ADP
ajmpe-262	12	11	kwara	kwara	PROPN
ajmpe-262	12	12	state	state	PROPN
ajmpe-262	12	13	college	college	PROPN
ajmpe-262	12	14	of	of	ADP
ajmpe-262	12	15	health	health	PROPN
ajmpe-262	12	16	technology	technology	NOUN
ajmpe-262	12	17	,	,	PUNCT
ajmpe-262	12	18	offa	offa	NOUN
ajmpe-262	12	19	,	,	PUNCT
ajmpe-262	12	20	nigeria	nigeria	PRON
ajmpe-262	12	21	:	:	PUNCT
ajmpe-262	12	22	a	a	DET
ajmpe-262	12	23	cross	cross	ADJ
ajmpe-262	12	24	-	-	ADJ
ajmpe-262	12	25	sectional	sectional	ADJ
ajmpe-262	12	26	study	study	NOUN
ajmpe-262	12	27	college	college	PROPN
ajmpe-262	12	28	of	of	ADP
ajmpe-262	12	29	health	health	PROPN
ajmpe-262	12	30	technology	technology	NOUN
ajmpe-262	12	31	,	,	PUNCT
ajmpe-262	12	32	offa	offa	PROPN
ajmpe-262	12	33	*	*	PUNCT
ajmpe-262	12	34	dr	dr	PROPN
ajmpe-262	12	35	raufu	raufu	PROPN
ajmpe-262	12	36	alabi	alabi	NOUN
ajmpe-262	12	37	aliyu1	aliyu1	ADJ
ajmpe-262	12	38	,	,	PUNCT
ajmpe-262	12	39	and	and	CCONJ
ajmpe-262	12	40	mathew	mathew	PROPN
ajmpe-262	12	41	folaranmi	folaranmi	PROPN
ajmpe-262	12	42	olaniyan2	olaniyan2	PROPN
ajmpe-262	13	1	1department	1department	NUM
ajmpe-262	13	2	of	of	ADP
ajmpe-262	13	3	medical	medical	ADJ
ajmpe-262	13	4	laboratory	laboratory	NOUN
ajmpe-262	13	5	science	science	NOUN
ajmpe-262	13	6	,	,	PUNCT
ajmpe-262	13	7	kwara	kwara	PROPN
ajmpe-262	13	8	state	state	PROPN
ajmpe-262	13	9	college	college	PROPN
ajmpe-262	13	10	of	of	ADP
ajmpe-262	13	11	health	health	PROPN
ajmpe-262	13	12	technology	technology	NOUN
ajmpe-262	13	13	,	,	PUNCT
ajmpe-262	13	14	offa	offa	NOUN
ajmpe-262	13	15	,	,	PUNCT
ajmpe-262	13	16	nigeria	nigeria	PRON
ajmpe-262	13	17	.	.	PUNCT
ajmpe-262	14	1	2department	2department	NUM
ajmpe-262	14	2	of	of	ADP
ajmpe-262	14	3	medical	medical	ADJ
ajmpe-262	14	4	laboratory	laboratory	NOUN
ajmpe-262	14	5	science	science	NOUN
ajmpe-262	14	6	,	,	PUNCT
ajmpe-262	14	7	kwara	kwara	PROPN
ajmpe-262	14	8	state	state	PROPN
ajmpe-262	14	9	college	college	PROPN
ajmpe-262	14	10	of	of	ADP
ajmpe-262	14	11	health	health	PROPN
ajmpe-262	14	12	technology	technology	NOUN
ajmpe-262	14	13	,	,	PUNCT
ajmpe-262	14	14	offa	offa	NOUN
ajmpe-262	14	15	,	,	PUNCT
ajmpe-262	14	16	nigeria	nigeria	PROPN
ajmpe-262	14	17	.	.	PUNCT
ajmpe-262	15	1	email	email	NOUN
ajmpe-262	15	2	:	:	PUNCT
ajmpe-262	15	3	aliyurauf@yahoo.com/	aliyurauf@yahoo.com/	PROPN
ajmpe-262	15	4	doi	doi	NOUN
ajmpe-262	15	5	:	:	PUNCT
ajmpe-262	15	6	https://doi.org/10.5281/zenodo.16793004	https://doi.org/10.5281/zenodo.16793004	X
ajmpe-262	15	7	abstract	abstract	ADJ
ajmpe-262	15	8	background	background	NOUN
ajmpe-262	15	9	:	:	PUNCT
ajmpe-262	15	10	hepatitis	hepatitis	PROPN
ajmpe-262	15	11	b	b	PROPN
ajmpe-262	15	12	virus	virus	NOUN
ajmpe-262	15	13	(	(	PUNCT
ajmpe-262	15	14	hbv	hbv	NOUN
ajmpe-262	15	15	)	)	PUNCT
ajmpe-262	15	16	infection	infection	NOUN
ajmpe-262	15	17	remains	remain	VERB
ajmpe-262	15	18	a	a	DET
ajmpe-262	15	19	significant	significant	ADJ
ajmpe-262	15	20	global	global	ADJ
ajmpe-262	15	21	public	public	ADJ
ajmpe-262	15	22	health	health	NOUN
ajmpe-262	15	23	concern	concern	NOUN
ajmpe-262	15	24	,	,	PUNCT
ajmpe-262	15	25	particularly	particularly	ADV
ajmpe-262	15	26	in	in	ADP
ajmpe-262	15	27	sub	sub	ADJ
ajmpe-262	15	28	-	-	ADJ
ajmpe-262	15	29	saharan	saharan	ADJ
ajmpe-262	15	30	africa	africa	PROPN
ajmpe-262	15	31	where	where	SCONJ
ajmpe-262	15	32	it	it	PRON
ajmpe-262	15	33	is	be	AUX
ajmpe-262	15	34	endemic	endemic	ADJ
ajmpe-262	15	35	.	.	PUNCT
ajmpe-262	16	1	this	this	DET
ajmpe-262	16	2	study	study	NOUN
ajmpe-262	16	3	aimed	aim	VERB
ajmpe-262	16	4	to	to	PART
ajmpe-262	16	5	determine	determine	VERB
ajmpe-262	16	6	the	the	DET
ajmpe-262	16	7	prevalence	prevalence	NOUN
ajmpe-262	16	8	of	of	ADP
ajmpe-262	16	9	hepatitis	hepatitis	PROPN
ajmpe-262	16	10	b	b	PROPN
ajmpe-262	16	11	surface	surface	NOUN
ajmpe-262	16	12	antigen	antigen	NOUN
ajmpe-262	16	13	(	(	PUNCT
ajmpe-262	16	14	hbsag	hbsag	NOUN
ajmpe-262	16	15	)	)	PUNCT
ajmpe-262	16	16	among	among	ADP
ajmpe-262	16	17	students	student	NOUN
ajmpe-262	16	18	of	of	ADP
ajmpe-262	16	19	kwara	kwara	PROPN
ajmpe-262	16	20	state	state	PROPN
ajmpe-262	16	21	college	college	PROPN
ajmpe-262	16	22	of	of	ADP
ajmpe-262	16	23	health	health	PROPN
ajmpe-262	16	24	technology	technology	NOUN
ajmpe-262	16	25	,	,	PUNCT
ajmpe-262	16	26	offa	offa	NOUN
ajmpe-262	16	27	,	,	PUNCT
ajmpe-262	16	28	nigeria	nigeria	PROPN
ajmpe-262	16	29	.	.	PUNCT
ajmpe-262	17	1	methods	method	NOUN
ajmpe-262	17	2	:	:	PUNCT
ajmpe-262	17	3	a	a	DET
ajmpe-262	17	4	cross	cross	ADJ
ajmpe-262	17	5	-	-	ADJ
ajmpe-262	17	6	sectional	sectional	ADJ
ajmpe-262	17	7	study	study	NOUN
ajmpe-262	17	8	was	be	AUX
ajmpe-262	17	9	conducted	conduct	VERB
ajmpe-262	17	10	between	between	ADP
ajmpe-262	17	11	july	july	PROPN
ajmpe-262	17	12	and	and	CCONJ
ajmpe-262	17	13	august	august	PROPN
ajmpe-262	17	14	2016	2016	NUM
ajmpe-262	17	15	involving	involve	VERB
ajmpe-262	17	16	100	100	NUM
ajmpe-262	17	17	randomly	randomly	ADV
ajmpe-262	17	18	selected	select	VERB
ajmpe-262	17	19	students	student	NOUN
ajmpe-262	17	20	from	from	ADP
ajmpe-262	17	21	various	various	ADJ
ajmpe-262	17	22	departments	department	NOUN
ajmpe-262	17	23	of	of	ADP
ajmpe-262	17	24	the	the	DET
ajmpe-262	17	25	college	college	NOUN
ajmpe-262	17	26	.	.	PUNCT
ajmpe-262	18	1	blood	blood	NOUN
ajmpe-262	18	2	samples	sample	NOUN
ajmpe-262	18	3	were	be	AUX
ajmpe-262	18	4	collected	collect	VERB
ajmpe-262	18	5	and	and	CCONJ
ajmpe-262	18	6	screened	screen	VERB
ajmpe-262	18	7	for	for	ADP
ajmpe-262	18	8	hbsag	hbsag	NOUN
ajmpe-262	18	9	using	use	VERB
ajmpe-262	18	10	a	a	DET
ajmpe-262	18	11	rapid	rapid	ADJ
ajmpe-262	18	12	chromatographic	chromatographic	ADJ
ajmpe-262	18	13	immunoassay	immunoassay	PROPN
ajmpe-262	18	14	.	.	PUNCT
ajmpe-262	19	1	data	datum	NOUN
ajmpe-262	19	2	on	on	ADP
ajmpe-262	19	3	age	age	NOUN
ajmpe-262	19	4	,	,	PUNCT
ajmpe-262	19	5	sex	sex	NOUN
ajmpe-262	19	6	,	,	PUNCT
ajmpe-262	19	7	and	and	CCONJ
ajmpe-262	19	8	department	department	NOUN
ajmpe-262	19	9	were	be	AUX
ajmpe-262	19	10	recorded	record	VERB
ajmpe-262	19	11	and	and	CCONJ
ajmpe-262	19	12	analyzed	analyze	VERB
ajmpe-262	19	13	using	use	VERB
ajmpe-262	19	14	descriptive	descriptive	ADJ
ajmpe-262	19	15	statistics	statistic	NOUN
ajmpe-262	19	16	.	.	PUNCT
ajmpe-262	20	1	results	result	NOUN
ajmpe-262	20	2	:	:	PUNCT
ajmpe-262	20	3	the	the	DET
ajmpe-262	20	4	overall	overall	ADJ
ajmpe-262	20	5	seroprevalence	seroprevalence	NOUN
ajmpe-262	20	6	of	of	ADP
ajmpe-262	20	7	hbsag	hbsag	NOUN
ajmpe-262	20	8	was	be	AUX
ajmpe-262	20	9	7	7	NUM
ajmpe-262	20	10	%	%	NOUN
ajmpe-262	20	11	(	(	PUNCT
ajmpe-262	20	12	n=7	n=7	PROPN
ajmpe-262	20	13	)	)	PUNCT
ajmpe-262	20	14	.	.	PUNCT
ajmpe-262	21	1	females	female	NOUN
ajmpe-262	21	2	showed	show	VERB
ajmpe-262	21	3	a	a	DET
ajmpe-262	21	4	higher	high	ADJ
ajmpe-262	21	5	prevalence	prevalence	NOUN
ajmpe-262	21	6	(	(	PUNCT
ajmpe-262	21	7	8.2	8.2	NUM
ajmpe-262	21	8	%	%	NOUN
ajmpe-262	21	9	)	)	PUNCT
ajmpe-262	21	10	compared	compare	VERB
ajmpe-262	21	11	to	to	ADP
ajmpe-262	21	12	males	male	NOUN
ajmpe-262	21	13	(	(	PUNCT
ajmpe-262	21	14	5.13	5.13	NUM
ajmpe-262	21	15	%	%	NOUN
ajmpe-262	21	16	)	)	PUNCT
ajmpe-262	21	17	.	.	PUNCT
ajmpe-262	22	1	students	student	NOUN
ajmpe-262	22	2	aged	age	VERB
ajmpe-262	22	3	18	18	NUM
ajmpe-262	22	4	-	-	SYM
ajmpe-262	22	5	21	21	NUM
ajmpe-262	22	6	years	year	NOUN
ajmpe-262	22	7	had	have	VERB
ajmpe-262	22	8	a	a	DET
ajmpe-262	22	9	higher	high	ADJ
ajmpe-262	22	10	prevalence	prevalence	NOUN
ajmpe-262	22	11	rate	rate	NOUN
ajmpe-262	22	12	(	(	PUNCT
ajmpe-262	22	13	12.5	12.5	NUM
ajmpe-262	22	14	%	%	NOUN
ajmpe-262	22	15	)	)	PUNCT
ajmpe-262	22	16	than	than	ADP
ajmpe-262	22	17	those	those	DET
ajmpe-262	22	18	aged	aged	ADJ
ajmpe-262	22	19	22	22	NUM
ajmpe-262	22	20	-	-	SYM
ajmpe-262	22	21	25	25	NUM
ajmpe-262	22	22	years	year	NOUN
ajmpe-262	22	23	(	(	PUNCT
ajmpe-262	22	24	4	4	NUM
ajmpe-262	22	25	%	%	NOUN
ajmpe-262	22	26	)	)	PUNCT
ajmpe-262	22	27	.	.	PUNCT
ajmpe-262	23	1	no	no	DET
ajmpe-262	23	2	hbsag	hbsag	ADJ
ajmpe-262	23	3	positivity	positivity	NOUN
ajmpe-262	23	4	was	be	AUX
ajmpe-262	23	5	detected	detect	VERB
ajmpe-262	23	6	in	in	ADP
ajmpe-262	23	7	students	student	NOUN
ajmpe-262	23	8	above	above	ADP
ajmpe-262	23	9	26	26	NUM
ajmpe-262	23	10	years	year	NOUN
ajmpe-262	23	11	.	.	PUNCT
ajmpe-262	24	1	analysis	analysis	NOUN
ajmpe-262	24	2	by	by	ADP
ajmpe-262	24	3	department	department	NOUN
ajmpe-262	24	4	revealed	reveal	VERB
ajmpe-262	24	5	the	the	DET
ajmpe-262	24	6	highest	high	ADJ
ajmpe-262	24	7	prevalence	prevalence	NOUN
ajmpe-262	24	8	in	in	ADP
ajmpe-262	24	9	environmental	environmental	ADJ
ajmpe-262	24	10	health	health	PROPN
ajmpe-262	24	11	department	department	NOUN
ajmpe-262	24	12	(	(	PUNCT
ajmpe-262	24	13	27.1	27.1	NUM
ajmpe-262	24	14	%	%	NOUN
ajmpe-262	24	15	)	)	PUNCT
ajmpe-262	24	16	,	,	PUNCT
ajmpe-262	24	17	followed	follow	VERB
ajmpe-262	24	18	by	by	ADP
ajmpe-262	24	19	public	public	ADJ
ajmpe-262	24	20	health	health	NOUN
ajmpe-262	24	21	and	and	CCONJ
ajmpe-262	24	22	community	community	NOUN
ajmpe-262	24	23	health	health	NOUN
ajmpe-262	24	24	departments	department	NOUN
ajmpe-262	24	25	(	(	PUNCT
ajmpe-262	24	26	9.1	9.1	NUM
ajmpe-262	24	27	%	%	NOUN
ajmpe-262	24	28	each	each	PRON
ajmpe-262	24	29	)	)	PUNCT
ajmpe-262	24	30	,	,	PUNCT
ajmpe-262	24	31	with	with	ADP
ajmpe-262	24	32	dental	dental	ADJ
ajmpe-262	24	33	health	health	NOUN
ajmpe-262	24	34	and	and	CCONJ
ajmpe-262	24	35	nutrition	nutrition	NOUN
ajmpe-262	24	36	departments	department	NOUN
ajmpe-262	24	37	each	each	PRON
ajmpe-262	24	38	showing	show	VERB
ajmpe-262	24	39	8.3	8.3	NUM
ajmpe-262	24	40	%	%	NOUN
ajmpe-262	24	41	prevalence	prevalence	NOUN
ajmpe-262	24	42	.	.	PUNCT
ajmpe-262	25	1	conclusion	conclusion	NOUN
ajmpe-262	25	2	:	:	PUNCT
ajmpe-262	25	3	this	this	DET
ajmpe-262	25	4	study	study	NOUN
ajmpe-262	25	5	demonstrates	demonstrate	VERB
ajmpe-262	25	6	a	a	DET
ajmpe-262	25	7	concerning	concern	VERB
ajmpe-262	25	8	prevalence	prevalence	NOUN
ajmpe-262	25	9	of	of	ADP
ajmpe-262	25	10	hbsag	hbsag	NOUN
ajmpe-262	25	11	among	among	ADP
ajmpe-262	25	12	college	college	NOUN
ajmpe-262	25	13	students	student	NOUN
ajmpe-262	25	14	,	,	PUNCT
ajmpe-262	25	15	particularly	particularly	ADV
ajmpe-262	25	16	in	in	ADP
ajmpe-262	25	17	younger	young	ADJ
ajmpe-262	25	18	females	female	NOUN
ajmpe-262	25	19	and	and	CCONJ
ajmpe-262	25	20	students	student	NOUN
ajmpe-262	25	21	of	of	ADP
ajmpe-262	25	22	environmental	environmental	ADJ
ajmpe-262	25	23	health	health	NOUN
ajmpe-262	25	24	.	.	PUNCT
ajmpe-262	26	1	the	the	DET
ajmpe-262	26	2	findings	finding	NOUN
ajmpe-262	26	3	highlight	highlight	VERB
ajmpe-262	26	4	the	the	DET
ajmpe-262	26	5	need	need	NOUN
ajmpe-262	26	6	for	for	ADP
ajmpe-262	26	7	targeted	target	VERB
ajmpe-262	26	8	hbv	hbv	NOUN
ajmpe-262	26	9	screening	screening	NOUN
ajmpe-262	26	10	,	,	PUNCT
ajmpe-262	26	11	vaccination	vaccination	NOUN
ajmpe-262	26	12	programs	program	NOUN
ajmpe-262	26	13	,	,	PUNCT
ajmpe-262	26	14	and	and	CCONJ
ajmpe-262	26	15	education	education	NOUN
ajmpe-262	26	16	about	about	ADP
ajmpe-262	26	17	preventive	preventive	ADJ
ajmpe-262	26	18	measures	measure	NOUN
ajmpe-262	26	19	within	within	ADP
ajmpe-262	26	20	tertiary	tertiary	ADJ
ajmpe-262	26	21	institutions	institution	NOUN
ajmpe-262	26	22	in	in	ADP
ajmpe-262	26	23	nigeria	nigeria	PROPN
ajmpe-262	26	24	.	.	PUNCT
ajmpe-262	27	1	keywords	keyword	NOUN
ajmpe-262	27	2	:	:	PUNCT
ajmpe-262	27	3	hepatitis	hepatitis	PROPN
ajmpe-262	27	4	b	b	PROPN
ajmpe-262	27	5	virus	virus	PROPN
ajmpe-262	27	6	,	,	PUNCT
ajmpe-262	27	7	hbsag	hbsag	NOUN
ajmpe-262	27	8	,	,	PUNCT
ajmpe-262	27	9	prevalence	prevalence	NOUN
ajmpe-262	27	10	,	,	PUNCT
ajmpe-262	27	11	students	student	NOUN
ajmpe-262	27	12	,	,	PUNCT
ajmpe-262	27	13	nigeria	nigeria	PROPN
ajmpe-262	27	14	introduction	introduction	NOUN
ajmpe-262	27	15	hepatitis	hepatitis	PROPN
ajmpe-262	27	16	b	b	PROPN
ajmpe-262	27	17	virus	virus	NOUN
ajmpe-262	27	18	(	(	PUNCT
ajmpe-262	27	19	hbv	hbv	NOUN
ajmpe-262	27	20	)	)	PUNCT
ajmpe-262	27	21	infection	infection	NOUN
ajmpe-262	27	22	represents	represent	VERB
ajmpe-262	27	23	a	a	DET
ajmpe-262	27	24	major	major	ADJ
ajmpe-262	27	25	global	global	ADJ
ajmpe-262	27	26	health	health	NOUN
ajmpe-262	27	27	challenge	challenge	NOUN
ajmpe-262	27	28	,	,	PUNCT
ajmpe-262	27	29	affecting	affect	VERB
ajmpe-262	27	30	approximately	approximately	ADV
ajmpe-262	27	31	2	2	NUM
ajmpe-262	27	32	billion	billion	NUM
ajmpe-262	27	33	people	people	NOUN
ajmpe-262	27	34	worldwide	worldwide	ADV
ajmpe-262	27	35	,	,	PUNCT
ajmpe-262	27	36	with	with	ADP
ajmpe-262	27	37	350	350	NUM
ajmpe-262	27	38	million	million	NUM
ajmpe-262	27	39	suffering	suffering	NOUN
ajmpe-262	27	40	from	from	ADP
ajmpe-262	27	41	chronic	chronic	ADJ
ajmpe-262	27	42	infection	infection	NOUN
ajmpe-262	27	43	(	(	PUNCT
ajmpe-262	27	44	who	who	PRON
ajmpe-262	27	45	,	,	PUNCT
ajmpe-262	27	46	2022	2022	NUM
ajmpe-262	27	47	)	)	PUNCT
ajmpe-262	27	48	.	.	PUNCT
ajmpe-262	28	1	the	the	DET
ajmpe-262	28	2	world	world	PROPN
ajmpe-262	28	3	health	health	PROPN
ajmpe-262	28	4	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-262	28	5	american	american	PROPN
ajmpe-262	28	6	journal	journal	PROPN
ajmpe-262	28	7	of	of	ADP
ajmpe-262	28	8	medical	medical	ADJ
ajmpe-262	28	9	and	and	CCONJ
ajmpe-262	28	10	physical	physical	ADJ
ajmpe-262	28	11	education	education	NOUN
ajmpe-262	28	12	vol.10	vol.10	NOUN
ajmpe-262	28	13	,	,	PUNCT
ajmpe-262	28	14	issue	issue	NOUN
ajmpe-262	28	15	4	4	NUM
ajmpe-262	28	16	;	;	PUNCT
ajmpe-262	28	17	july	july	PROPN
ajmpe-262	28	18	-	-	PUNCT
ajmpe-262	28	19	august	august	PROPN
ajmpe-262	28	20	2025	2025	NUM
ajmpe-262	28	21	;	;	PUNCT
ajmpe-262	28	22	issn	issn	PROPN
ajmpe-262	28	23	:	:	PUNCT
ajmpe-262	28	24	2994	2994	NUM
ajmpe-262	28	25	-	-	SYM
ajmpe-262	28	26	0524	0524	NUM
ajmpe-262	28	27	impact	impact	NOUN
ajmpe-262	28	28	factor	factor	NOUN
ajmpe-262	28	29	:	:	PUNCT
ajmpe-262	28	30	7.06	7.06	NUM
ajmpe-262	28	31	1252	1252	NUM
ajmpe-262	28	32	columbia	columbia	PROPN
ajmpe-262	28	33	rd	rd	PROPN
ajmpe-262	28	34	nw	nw	PROPN
ajmpe-262	28	35	,	,	PUNCT
ajmpe-262	28	36	washington	washington	PROPN
ajmpe-262	28	37	dc	dc	PROPN
ajmpe-262	28	38	,	,	PUNCT
ajmpe-262	28	39	united	united	PROPN
ajmpe-262	28	40	states	states	PROPN
ajmpe-262	28	41	https://topjournals.org/index.php/	https://topjournals.org/index.php/	PROPN
ajmpe-262	28	42	ajmpe	ajmpe	NOUN
ajmpe-262	28	43	;	;	PUNCT
ajmpe-262	28	44	mail	mail	NOUN
ajmpe-262	28	45	:	:	PUNCT
ajmpe-262	28	46	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-262	28	47	2	2	NUM
ajmpe-262	29	1	|	|	ADV
ajmpe-262	29	2	a	a	DET
ajmpe-262	29	3	m	m	NOUN
ajmpe-262	29	4	e	e	NOUN
ajmpe-262	29	5	r	r	NOUN
ajmpe-262	29	6	i	i	NOUN
ajmpe-262	29	7	c	c	VERB
ajmpe-262	29	8	a	a	DET
ajmpe-262	29	9	n	n	NOUN
ajmpe-262	30	1	j	j	NOUN
ajmpe-262	30	2	o	o	X
ajmpe-262	30	3	u	u	NOUN
ajmpe-262	30	4	r	r	NOUN
ajmpe-262	30	5	n	n	NOUN
ajmpe-262	30	6	a	a	DET
ajmpe-262	30	7	l	l	NOUN
ajmpe-262	30	8	o	o	X
ajmpe-262	31	1	f	f	X
ajmpe-262	31	2	m	m	NOUN
ajmpe-262	31	3	e	e	NOUN
ajmpe-262	32	1	d	d	NOUN
ajmpe-262	32	2	i	i	PRON
ajmpe-262	32	3	c	c	VERB
ajmpe-262	32	4	a	a	DET
ajmpe-262	32	5	l	l	NOUN
ajmpe-262	32	6	a	a	X
ajmpe-262	32	7	n	n	NOUN
ajmpe-262	33	1	d	d	NOUN
ajmpe-262	33	2	p	p	NOUN
ajmpe-262	33	3	h	h	NOUN
ajmpe-262	33	4	y	y	NOUN
ajmpe-262	33	5	s	s	VERB
ajmpe-262	34	1	i	i	INTJ
ajmpe-262	34	2	c	c	VERB
ajmpe-262	34	3	a	a	DET
ajmpe-262	34	4	l	l	NOUN
ajmpe-262	34	5	e	e	NOUN
ajmpe-262	34	6	d	d	X
ajmpe-262	34	7	u	u	X
ajmpe-262	34	8	c	c	PROPN
ajmpe-262	35	1	a	a	DET
ajmpe-262	35	2	t	t	NOUN
ajmpe-262	36	1	i	i	PRON
ajmpe-262	36	2	o	o	VERB
ajmpe-262	37	1	n	n	CCONJ
ajmpe-262	37	2	|	|	ADV
ajmpe-262	37	3	https://topjournals.org/index.php/	https://topjournals.org/index.php/	INTJ
ajmpe-262	37	4	ajmpe	ajmpe	PROPN
ajmpe-262	37	5	organization	organization	PROPN
ajmpe-262	37	6	considers	consider	VERB
ajmpe-262	37	7	hbv	hbv	NOUN
ajmpe-262	37	8	second	second	ADV
ajmpe-262	37	9	only	only	ADV
ajmpe-262	37	10	to	to	AUX
ajmpe-262	37	11	tobacco	tobacco	NOUN
ajmpe-262	37	12	among	among	ADP
ajmpe-262	37	13	liver	liver	NOUN
ajmpe-262	37	14	carcinogens	carcinogen	NOUN
ajmpe-262	37	15	.	.	PUNCT
ajmpe-262	38	1	in	in	ADP
ajmpe-262	38	2	sub	sub	ADJ
ajmpe-262	38	3	-	-	ADJ
ajmpe-262	38	4	saharan	saharan	ADJ
ajmpe-262	38	5	africa	africa	PROPN
ajmpe-262	38	6	and	and	CCONJ
ajmpe-262	38	7	east	east	PROPN
ajmpe-262	38	8	asia	asia	PROPN
ajmpe-262	38	9	,	,	PUNCT
ajmpe-262	38	10	approximately	approximately	ADV
ajmpe-262	38	11	10	10	NUM
ajmpe-262	38	12	%	%	NOUN
ajmpe-262	38	13	of	of	ADP
ajmpe-262	38	14	the	the	DET
ajmpe-262	38	15	population	population	NOUN
ajmpe-262	38	16	is	be	AUX
ajmpe-262	38	17	chronically	chronically	ADV
ajmpe-262	38	18	infected	infect	VERB
ajmpe-262	38	19	with	with	ADP
ajmpe-262	38	20	hbv	hbv	NOUN
ajmpe-262	38	21	,	,	PUNCT
ajmpe-262	38	22	with	with	ADP
ajmpe-262	38	23	significant	significant	ADJ
ajmpe-262	38	24	risk	risk	NOUN
ajmpe-262	38	25	of	of	ADP
ajmpe-262	38	26	developing	develop	VERB
ajmpe-262	38	27	complications	complication	NOUN
ajmpe-262	38	28	such	such	ADJ
ajmpe-262	38	29	as	as	ADP
ajmpe-262	38	30	liver	liver	NOUN
ajmpe-262	38	31	cirrhosis	cirrhosis	NOUN
ajmpe-262	38	32	and	and	CCONJ
ajmpe-262	38	33	hepatocellular	hepatocellular	ADJ
ajmpe-262	38	34	carcinoma	carcinoma	NOUN
ajmpe-262	38	35	(	(	PUNCT
ajmpe-262	38	36	spearman	spearman	NOUN
ajmpe-262	38	37	et	et	PROPN
ajmpe-262	38	38	al	al	PROPN
ajmpe-262	38	39	.	.	PROPN
ajmpe-262	38	40	,	,	PUNCT
ajmpe-262	38	41	2017	2017	NUM
ajmpe-262	38	42	)	)	PUNCT
ajmpe-262	38	43	.	.	PUNCT
ajmpe-262	39	1	hbv	hbv	NOUN
ajmpe-262	39	2	is	be	AUX
ajmpe-262	39	3	a	a	DET
ajmpe-262	39	4	dna	dna	PROPN
ajmpe-262	39	5	virus	virus	NOUN
ajmpe-262	39	6	belonging	belong	VERB
ajmpe-262	39	7	to	to	ADP
ajmpe-262	39	8	the	the	DET
ajmpe-262	39	9	hepadnaviridae	hepadnaviridae	NOUN
ajmpe-262	39	10	family	family	NOUN
ajmpe-262	39	11	that	that	PRON
ajmpe-262	39	12	can	can	AUX
ajmpe-262	39	13	cause	cause	VERB
ajmpe-262	39	14	both	both	DET
ajmpe-262	39	15	acute	acute	ADJ
ajmpe-262	39	16	and	and	CCONJ
ajmpe-262	39	17	chronic	chronic	ADJ
ajmpe-262	39	18	liver	liver	NOUN
ajmpe-262	39	19	infections	infection	NOUN
ajmpe-262	39	20	.	.	PUNCT
ajmpe-262	40	1	transmission	transmission	NOUN
ajmpe-262	40	2	occurs	occur	VERB
ajmpe-262	40	3	through	through	ADP
ajmpe-262	40	4	contact	contact	NOUN
ajmpe-262	40	5	with	with	ADP
ajmpe-262	40	6	infected	infected	ADJ
ajmpe-262	40	7	blood	blood	NOUN
ajmpe-262	40	8	or	or	CCONJ
ajmpe-262	40	9	body	body	NOUN
ajmpe-262	40	10	fluids	fluid	NOUN
ajmpe-262	40	11	,	,	PUNCT
ajmpe-262	40	12	with	with	ADP
ajmpe-262	40	13	perinatal	perinatal	ADJ
ajmpe-262	40	14	,	,	PUNCT
ajmpe-262	40	15	horizontal	horizontal	ADJ
ajmpe-262	40	16	,	,	PUNCT
ajmpe-262	40	17	and	and	CCONJ
ajmpe-262	40	18	sexual	sexual	ADJ
ajmpe-262	40	19	transmission	transmission	NOUN
ajmpe-262	40	20	being	be	AUX
ajmpe-262	40	21	the	the	DET
ajmpe-262	40	22	predominant	predominant	ADJ
ajmpe-262	40	23	routes	route	NOUN
ajmpe-262	40	24	(	(	PUNCT
ajmpe-262	40	25	ott	ott	PROPN
ajmpe-262	40	26	et	et	PROPN
ajmpe-262	40	27	al	al	PROPN
ajmpe-262	40	28	.	.	PROPN
ajmpe-262	40	29	,	,	PUNCT
ajmpe-262	40	30	2012	2012	NUM
ajmpe-262	40	31	)	)	PUNCT
ajmpe-262	40	32	.	.	PUNCT
ajmpe-262	41	1	in	in	ADP
ajmpe-262	41	2	africa	africa	PROPN
ajmpe-262	41	3	,	,	PUNCT
ajmpe-262	41	4	epidemiological	epidemiological	ADJ
ajmpe-262	41	5	studies	study	NOUN
ajmpe-262	41	6	have	have	AUX
ajmpe-262	41	7	shown	show	VERB
ajmpe-262	41	8	that	that	SCONJ
ajmpe-262	41	9	hbv	hbv	NOUN
ajmpe-262	41	10	infection	infection	NOUN
ajmpe-262	41	11	commonly	commonly	ADV
ajmpe-262	41	12	occurs	occur	VERB
ajmpe-262	41	13	during	during	ADP
ajmpe-262	41	14	childhood	childhood	NOUN
ajmpe-262	41	15	,	,	PUNCT
ajmpe-262	41	16	resulting	result	VERB
ajmpe-262	41	17	in	in	ADP
ajmpe-262	41	18	an	an	DET
ajmpe-262	41	19	increased	increase	VERB
ajmpe-262	41	20	tendency	tendency	NOUN
ajmpe-262	41	21	toward	toward	ADP
ajmpe-262	41	22	chronicity	chronicity	NOUN
ajmpe-262	41	23	(	(	PUNCT
ajmpe-262	41	24	lemoine	lemoine	PROPN
ajmpe-262	41	25	et	et	PROPN
ajmpe-262	41	26	al	al	PROPN
ajmpe-262	41	27	.	.	PROPN
ajmpe-262	41	28	,	,	PUNCT
ajmpe-262	41	29	2013	2013	NUM
ajmpe-262	41	30	)	)	PUNCT
ajmpe-262	41	31	.	.	PUNCT
ajmpe-262	42	1	the	the	DET
ajmpe-262	42	2	clinical	clinical	ADJ
ajmpe-262	42	3	manifestations	manifestation	NOUN
ajmpe-262	42	4	of	of	ADP
ajmpe-262	42	5	hbv	hbv	NOUN
ajmpe-262	42	6	infection	infection	NOUN
ajmpe-262	42	7	range	range	NOUN
ajmpe-262	42	8	from	from	ADP
ajmpe-262	42	9	asymptomatic	asymptomatic	ADJ
ajmpe-262	42	10	carrier	carrier	NOUN
ajmpe-262	42	11	state	state	NOUN
ajmpe-262	42	12	to	to	ADP
ajmpe-262	42	13	fulminant	fulminant	ADJ
ajmpe-262	42	14	hepatitis	hepatitis	NOUN
ajmpe-262	42	15	.	.	PUNCT
ajmpe-262	43	1	after	after	ADP
ajmpe-262	43	2	an	an	DET
ajmpe-262	43	3	incubation	incubation	NOUN
ajmpe-262	43	4	period	period	NOUN
ajmpe-262	43	5	,	,	PUNCT
ajmpe-262	43	6	patients	patient	NOUN
ajmpe-262	43	7	typically	typically	ADV
ajmpe-262	43	8	present	present	VERB
ajmpe-262	43	9	with	with	ADP
ajmpe-262	43	10	prodromal	prodromal	ADJ
ajmpe-262	43	11	symptoms	symptom	NOUN
ajmpe-262	43	12	including	include	VERB
ajmpe-262	43	13	chills	chill	NOUN
ajmpe-262	43	14	,	,	PUNCT
ajmpe-262	43	15	headache	headache	NOUN
ajmpe-262	43	16	,	,	PUNCT
ajmpe-262	43	17	nausea	nausea	NOUN
ajmpe-262	43	18	,	,	PUNCT
ajmpe-262	43	19	and	and	CCONJ
ajmpe-262	43	20	vomiting	vomiting	NOUN
ajmpe-262	43	21	,	,	PUNCT
ajmpe-262	43	22	which	which	PRON
ajmpe-262	43	23	may	may	AUX
ajmpe-262	43	24	precede	precede	VERB
ajmpe-262	43	25	jaundice	jaundice	NOUN
ajmpe-262	43	26	.	.	PUNCT
ajmpe-262	44	1	while	while	SCONJ
ajmpe-262	44	2	most	most	ADJ
ajmpe-262	44	3	acute	acute	ADJ
ajmpe-262	44	4	hbv	hbv	NOUN
ajmpe-262	44	5	infections	infection	NOUN
ajmpe-262	44	6	resolve	resolve	VERB
ajmpe-262	44	7	spontaneously	spontaneously	ADV
ajmpe-262	44	8	,	,	PUNCT
ajmpe-262	44	9	chronically	chronically	ADV
ajmpe-262	44	10	infected	infect	VERB
ajmpe-262	44	11	individuals	individual	NOUN
ajmpe-262	44	12	have	have	VERB
ajmpe-262	44	13	elevated	elevate	VERB
ajmpe-262	44	14	risks	risk	NOUN
ajmpe-262	44	15	of	of	ADP
ajmpe-262	44	16	developing	develop	VERB
ajmpe-262	44	17	cirrhosis	cirrhosis	NOUN
ajmpe-262	44	18	and	and	CCONJ
ajmpe-262	44	19	hepatocellular	hepatocellular	ADJ
ajmpe-262	44	20	carcinoma	carcinoma	NOUN
ajmpe-262	44	21	(	(	PUNCT
ajmpe-262	44	22	trépo	trépo	NOUN
ajmpe-262	44	23	et	et	NOUN
ajmpe-262	44	24	al	al	PROPN
ajmpe-262	44	25	.	.	PROPN
ajmpe-262	44	26	,	,	PUNCT
ajmpe-262	44	27	2014	2014	NUM
ajmpe-262	44	28	)	)	PUNCT
ajmpe-262	44	29	.	.	PUNCT
ajmpe-262	45	1	diagnosis	diagnosis	NOUN
ajmpe-262	45	2	of	of	ADP
ajmpe-262	45	3	hbv	hbv	NOUN
ajmpe-262	45	4	infection	infection	NOUN
ajmpe-262	45	5	is	be	AUX
ajmpe-262	45	6	primarily	primarily	ADV
ajmpe-262	45	7	confirmed	confirm	VERB
ajmpe-262	45	8	through	through	ADP
ajmpe-262	45	9	serological	serological	ADJ
ajmpe-262	45	10	testing	testing	NOUN
ajmpe-262	45	11	,	,	PUNCT
ajmpe-262	45	12	with	with	ADP
ajmpe-262	45	13	hbsag	hbsag	NOUN
ajmpe-262	45	14	being	be	AUX
ajmpe-262	45	15	the	the	DET
ajmpe-262	45	16	most	most	ADV
ajmpe-262	45	17	important	important	ADJ
ajmpe-262	45	18	marker	marker	NOUN
ajmpe-262	45	19	.	.	PUNCT
ajmpe-262	46	1	hbsag	hbsag	NOUN
ajmpe-262	46	2	appears	appear	VERB
ajmpe-262	46	3	during	during	ADP
ajmpe-262	46	4	the	the	DET
ajmpe-262	46	5	incubation	incubation	NOUN
ajmpe-262	46	6	period	period	NOUN
ajmpe-262	46	7	and	and	CCONJ
ajmpe-262	46	8	persists	persist	VERB
ajmpe-262	46	9	during	during	ADP
ajmpe-262	46	10	acute	acute	ADJ
ajmpe-262	46	11	disease	disease	NOUN
ajmpe-262	46	12	,	,	PUNCT
ajmpe-262	46	13	disappearing	disappear	VERB
ajmpe-262	46	14	after	after	ADP
ajmpe-262	46	15	one	one	NUM
ajmpe-262	46	16	to	to	ADP
ajmpe-262	46	17	two	two	NUM
ajmpe-262	46	18	months	month	NOUN
ajmpe-262	46	19	following	follow	VERB
ajmpe-262	46	20	jaundice	jaundice	NOUN
ajmpe-262	46	21	in	in	ADP
ajmpe-262	46	22	resolving	resolve	VERB
ajmpe-262	46	23	infections	infection	NOUN
ajmpe-262	46	24	.	.	PUNCT
ajmpe-262	47	1	persistence	persistence	NOUN
ajmpe-262	47	2	of	of	ADP
ajmpe-262	47	3	hbsag	hbsag	NOUN
ajmpe-262	47	4	for	for	ADP
ajmpe-262	47	5	more	more	ADJ
ajmpe-262	47	6	than	than	ADP
ajmpe-262	47	7	6	6	NUM
ajmpe-262	47	8	months	month	NOUN
ajmpe-262	47	9	indicates	indicate	VERB
ajmpe-262	47	10	a	a	DET
ajmpe-262	47	11	carrier	carrier	NOUN
ajmpe-262	47	12	state	state	NOUN
ajmpe-262	47	13	and	and	CCONJ
ajmpe-262	47	14	risk	risk	NOUN
ajmpe-262	47	15	for	for	ADP
ajmpe-262	47	16	chronic	chronic	ADJ
ajmpe-262	47	17	hepatitis	hepatitis	NOUN
ajmpe-262	47	18	(	(	PUNCT
ajmpe-262	47	19	liaw	liaw	PROPN
ajmpe-262	47	20	&	&	CCONJ
ajmpe-262	47	21	chu	chu	PROPN
ajmpe-262	47	22	,	,	PUNCT
ajmpe-262	47	23	2009	2009	NUM
ajmpe-262	47	24	)	)	PUNCT
ajmpe-262	47	25	.	.	PUNCT
ajmpe-262	48	1	despite	despite	SCONJ
ajmpe-262	48	2	the	the	DET
ajmpe-262	48	3	availability	availability	NOUN
ajmpe-262	48	4	of	of	ADP
ajmpe-262	48	5	an	an	DET
ajmpe-262	48	6	effective	effective	ADJ
ajmpe-262	48	7	vaccine	vaccine	NOUN
ajmpe-262	48	8	against	against	ADP
ajmpe-262	48	9	hbv	hbv	NOUN
ajmpe-262	48	10	since	since	SCONJ
ajmpe-262	48	11	1982	1982	NUM
ajmpe-262	48	12	,	,	PUNCT
ajmpe-262	48	13	and	and	CCONJ
ajmpe-262	48	14	its	its	PRON
ajmpe-262	48	15	integration	integration	NOUN
ajmpe-262	48	16	into	into	ADP
ajmpe-262	48	17	the	the	DET
ajmpe-262	48	18	expanded	expand	VERB
ajmpe-262	48	19	programme	programme	NOUN
ajmpe-262	48	20	on	on	ADP
ajmpe-262	48	21	immunization	immunization	NOUN
ajmpe-262	48	22	(	(	PUNCT
ajmpe-262	48	23	epi	epi	NOUN
ajmpe-262	48	24	)	)	PUNCT
ajmpe-262	48	25	in	in	ADP
ajmpe-262	48	26	many	many	ADJ
ajmpe-262	48	27	countries	country	NOUN
ajmpe-262	48	28	,	,	PUNCT
ajmpe-262	48	29	hbv	hbv	NOUN
ajmpe-262	48	30	infection	infection	NOUN
ajmpe-262	48	31	continues	continue	VERB
ajmpe-262	48	32	to	to	PART
ajmpe-262	48	33	be	be	AUX
ajmpe-262	48	34	a	a	DET
ajmpe-262	48	35	significant	significant	ADJ
ajmpe-262	48	36	public	public	ADJ
ajmpe-262	48	37	health	health	NOUN
ajmpe-262	48	38	issue	issue	NOUN
ajmpe-262	48	39	in	in	ADP
ajmpe-262	48	40	nigeria	nigeria	PROPN
ajmpe-262	48	41	.	.	PUNCT
ajmpe-262	49	1	various	various	ADJ
ajmpe-262	49	2	studies	study	NOUN
ajmpe-262	49	3	have	have	AUX
ajmpe-262	49	4	reported	report	VERB
ajmpe-262	49	5	prevalence	prevalence	NOUN
ajmpe-262	49	6	rates	rate	NOUN
ajmpe-262	49	7	ranging	range	VERB
ajmpe-262	49	8	from	from	ADP
ajmpe-262	49	9	2.4	2.4	NUM
ajmpe-262	49	10	%	%	NOUN
ajmpe-262	49	11	to	to	ADP
ajmpe-262	49	12	18.4	18.4	NUM
ajmpe-262	49	13	%	%	NOUN
ajmpe-262	49	14	across	across	ADP
ajmpe-262	49	15	different	different	ADJ
ajmpe-262	49	16	population	population	NOUN
ajmpe-262	49	17	groups	group	NOUN
ajmpe-262	49	18	in	in	ADP
ajmpe-262	49	19	nigeria	nigeria	PROPN
ajmpe-262	49	20	(	(	PUNCT
ajmpe-262	49	21	musa	musa	PROPN
ajmpe-262	49	22	et	et	PROPN
ajmpe-262	49	23	al	al	PROPN
ajmpe-262	49	24	.	.	PROPN
ajmpe-262	49	25	,	,	PUNCT
ajmpe-262	49	26	2015	2015	NUM
ajmpe-262	49	27	)	)	PUNCT
ajmpe-262	49	28	.	.	PUNCT
ajmpe-262	50	1	college	college	NOUN
ajmpe-262	50	2	students	student	NOUN
ajmpe-262	50	3	represent	represent	VERB
ajmpe-262	50	4	a	a	DET
ajmpe-262	50	5	demographic	demographic	ADJ
ajmpe-262	50	6	group	group	NOUN
ajmpe-262	50	7	that	that	PRON
ajmpe-262	50	8	may	may	AUX
ajmpe-262	50	9	be	be	AUX
ajmpe-262	50	10	at	at	ADP
ajmpe-262	50	11	higher	high	ADJ
ajmpe-262	50	12	risk	risk	NOUN
ajmpe-262	50	13	for	for	ADP
ajmpe-262	50	14	hbv	hbv	NOUN
ajmpe-262	50	15	infection	infection	NOUN
ajmpe-262	50	16	due	due	ADP
ajmpe-262	50	17	to	to	ADP
ajmpe-262	50	18	lifestyle	lifestyle	NOUN
ajmpe-262	50	19	factors	factor	NOUN
ajmpe-262	50	20	including	include	VERB
ajmpe-262	50	21	potential	potential	ADJ
ajmpe-262	50	22	unsafe	unsafe	ADJ
ajmpe-262	50	23	sexual	sexual	ADJ
ajmpe-262	50	24	practices	practice	NOUN
ajmpe-262	50	25	,	,	PUNCT
ajmpe-262	50	26	sharing	sharing	NOUN
ajmpe-262	50	27	of	of	ADP
ajmpe-262	50	28	personal	personal	ADJ
ajmpe-262	50	29	items	item	NOUN
ajmpe-262	50	30	,	,	PUNCT
ajmpe-262	50	31	and	and	CCONJ
ajmpe-262	50	32	participation	participation	NOUN
ajmpe-262	50	33	in	in	ADP
ajmpe-262	50	34	activities	activity	NOUN
ajmpe-262	50	35	with	with	ADP
ajmpe-262	50	36	risk	risk	NOUN
ajmpe-262	50	37	of	of	ADP
ajmpe-262	50	38	blood	blood	NOUN
ajmpe-262	50	39	exposure	exposure	NOUN
ajmpe-262	50	40	.	.	PUNCT
ajmpe-262	51	1	understanding	understand	VERB
ajmpe-262	51	2	the	the	DET
ajmpe-262	51	3	epidemiology	epidemiology	NOUN
ajmpe-262	51	4	of	of	ADP
ajmpe-262	51	5	hbv	hbv	NOUN
ajmpe-262	51	6	infection	infection	NOUN
ajmpe-262	51	7	among	among	ADP
ajmpe-262	51	8	this	this	DET
ajmpe-262	51	9	population	population	NOUN
ajmpe-262	51	10	is	be	AUX
ajmpe-262	51	11	crucial	crucial	ADJ
ajmpe-262	51	12	for	for	ADP
ajmpe-262	51	13	developing	develop	VERB
ajmpe-262	51	14	targeted	target	VERB
ajmpe-262	51	15	preventive	preventive	ADJ
ajmpe-262	51	16	strategies	strategy	NOUN
ajmpe-262	51	17	(	(	PUNCT
ajmpe-262	51	18	eni	eni	NOUN
ajmpe-262	51	19	et	et	PROPN
ajmpe-262	51	20	al	al	PROPN
ajmpe-262	51	21	.	.	PROPN
ajmpe-262	51	22	,	,	PUNCT
ajmpe-262	51	23	2018	2018	NUM
ajmpe-262	51	24	)	)	PUNCT
ajmpe-262	51	25	.	.	PUNCT
ajmpe-262	52	1	the	the	DET
ajmpe-262	52	2	present	present	ADJ
ajmpe-262	52	3	study	study	NOUN
ajmpe-262	52	4	aimed	aim	VERB
ajmpe-262	52	5	to	to	PART
ajmpe-262	52	6	determine	determine	VERB
ajmpe-262	52	7	the	the	DET
ajmpe-262	52	8	prevalence	prevalence	NOUN
ajmpe-262	52	9	of	of	ADP
ajmpe-262	52	10	hbsag	hbsag	NOUN
ajmpe-262	52	11	among	among	ADP
ajmpe-262	52	12	students	student	NOUN
ajmpe-262	52	13	of	of	ADP
ajmpe-262	52	14	kwara	kwara	PROPN
ajmpe-262	52	15	state	state	PROPN
ajmpe-262	52	16	college	college	PROPN
ajmpe-262	52	17	of	of	ADP
ajmpe-262	52	18	health	health	PROPN
ajmpe-262	52	19	technology	technology	NOUN
ajmpe-262	52	20	,	,	PUNCT
ajmpe-262	52	21	offa	offa	NOUN
ajmpe-262	52	22	,	,	PUNCT
ajmpe-262	52	23	nigeria	nigeria	PRON
ajmpe-262	52	24	,	,	PUNCT
ajmpe-262	52	25	and	and	CCONJ
ajmpe-262	52	26	to	to	PART
ajmpe-262	52	27	identify	identify	VERB
ajmpe-262	52	28	demographic	demographic	ADJ
ajmpe-262	52	29	factors	factor	NOUN
ajmpe-262	52	30	associated	associate	VERB
ajmpe-262	52	31	with	with	ADP
ajmpe-262	52	32	hbv	hbv	NOUN
ajmpe-262	52	33	infection	infection	NOUN
ajmpe-262	52	34	in	in	ADP
ajmpe-262	52	35	this	this	DET
ajmpe-262	52	36	population	population	NOUN
ajmpe-262	52	37	.	.	PUNCT
ajmpe-262	53	1	materials	material	NOUN
ajmpe-262	53	2	and	and	CCONJ
ajmpe-262	53	3	methods	method	NOUN
ajmpe-262	53	4	study	study	NOUN
ajmpe-262	53	5	design	design	NOUN
ajmpe-262	53	6	and	and	CCONJ
ajmpe-262	53	7	population	population	NOUN
ajmpe-262	53	8	a	a	DET
ajmpe-262	53	9	cross	cross	ADJ
ajmpe-262	53	10	-	-	ADJ
ajmpe-262	53	11	sectional	sectional	ADJ
ajmpe-262	53	12	study	study	NOUN
ajmpe-262	53	13	was	be	AUX
ajmpe-262	53	14	conducted	conduct	VERB
ajmpe-262	53	15	between	between	ADP
ajmpe-262	53	16	july	july	PROPN
ajmpe-262	53	17	and	and	CCONJ
ajmpe-262	53	18	august	august	PROPN
ajmpe-262	53	19	2016	2016	NUM
ajmpe-262	53	20	at	at	ADP
ajmpe-262	53	21	kwara	kwara	PROPN
ajmpe-262	53	22	state	state	PROPN
ajmpe-262	53	23	college	college	PROPN
ajmpe-262	53	24	of	of	ADP
ajmpe-262	53	25	health	health	PROPN
ajmpe-262	53	26	technology	technology	NOUN
ajmpe-262	53	27	,	,	PUNCT
ajmpe-262	53	28	offa	offa	NOUN
ajmpe-262	53	29	,	,	PUNCT
ajmpe-262	53	30	nigeria	nigeria	PROPN
ajmpe-262	53	31	.	.	PUNCT
ajmpe-262	54	1	the	the	DET
ajmpe-262	54	2	college	college	NOUN
ajmpe-262	54	3	is	be	AUX
ajmpe-262	54	4	located	locate	VERB
ajmpe-262	54	5	in	in	ADP
ajmpe-262	54	6	offa	offa	NOUN
ajmpe-262	54	7	,	,	PUNCT
ajmpe-262	54	8	the	the	DET
ajmpe-262	54	9	second	second	ADV
ajmpe-262	54	10	largest	large	ADJ
ajmpe-262	54	11	town	town	NOUN
ajmpe-262	54	12	in	in	ADP
ajmpe-262	54	13	kwara	kwara	PROPN
ajmpe-262	54	14	state	state	PROPN
ajmpe-262	54	15	with	with	ADP
ajmpe-262	54	16	a	a	DET
ajmpe-262	54	17	population	population	NOUN
ajmpe-262	54	18	of	of	ADP
ajmpe-262	54	19	approximately	approximately	ADV
ajmpe-262	54	20	90,000	90,000	NUM
ajmpe-262	54	21	inhabitants	inhabitant	NOUN
ajmpe-262	54	22	.	.	PUNCT
ajmpe-262	55	1	the	the	DET
ajmpe-262	55	2	college	college	NOUN
ajmpe-262	55	3	has	have	VERB
ajmpe-262	55	4	about	about	ADV
ajmpe-262	55	5	ten	ten	NUM
ajmpe-262	55	6	departments	department	NOUN
ajmpe-262	55	7	with	with	ADP
ajmpe-262	55	8	approximately	approximately	ADV
ajmpe-262	55	9	10,000	10,000	NUM
ajmpe-262	55	10	students	student	NOUN
ajmpe-262	55	11	.	.	PUNCT
ajmpe-262	56	1	a	a	DET
ajmpe-262	56	2	total	total	NOUN
ajmpe-262	56	3	of	of	ADP
ajmpe-262	56	4	100	100	NUM
ajmpe-262	56	5	students	student	NOUN
ajmpe-262	56	6	were	be	AUX
ajmpe-262	56	7	randomly	randomly	ADV
ajmpe-262	56	8	selected	select	VERB
ajmpe-262	56	9	from	from	ADP
ajmpe-262	56	10	various	various	ADJ
ajmpe-262	56	11	departments	department	NOUN
ajmpe-262	56	12	of	of	ADP
ajmpe-262	56	13	the	the	DET
ajmpe-262	56	14	college	college	NOUN
ajmpe-262	56	15	.	.	PUNCT
ajmpe-262	57	1	the	the	DET
ajmpe-262	57	2	study	study	NOUN
ajmpe-262	57	3	population	population	NOUN
ajmpe-262	57	4	comprised	comprise	VERB
ajmpe-262	57	5	39	39	NUM
ajmpe-262	57	6	males	male	NOUN
ajmpe-262	57	7	and	and	CCONJ
ajmpe-262	57	8	61	61	NUM
ajmpe-262	57	9	females	female	NOUN
ajmpe-262	57	10	,	,	PUNCT
ajmpe-262	57	11	with	with	ADP
ajmpe-262	57	12	ages	age	NOUN
ajmpe-262	57	13	ranging	range	VERB
ajmpe-262	57	14	from	from	ADP
ajmpe-262	57	15	18	18	NUM
ajmpe-262	57	16	to	to	PART
ajmpe-262	57	17	28	28	NUM
ajmpe-262	57	18	years	year	NOUN
ajmpe-262	57	19	.	.	PUNCT
ajmpe-262	58	1	the	the	DET
ajmpe-262	58	2	distribution	distribution	NOUN
ajmpe-262	58	3	of	of	ADP
ajmpe-262	58	4	participants	participant	NOUN
ajmpe-262	58	5	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-262	58	6	american	american	PROPN
ajmpe-262	58	7	journal	journal	PROPN
ajmpe-262	58	8	of	of	ADP
ajmpe-262	58	9	medical	medical	ADJ
ajmpe-262	58	10	and	and	CCONJ
ajmpe-262	58	11	physical	physical	ADJ
ajmpe-262	58	12	education	education	NOUN
ajmpe-262	58	13	vol.10	vol.10	NOUN
ajmpe-262	58	14	,	,	PUNCT
ajmpe-262	58	15	issue	issue	NOUN
ajmpe-262	58	16	4	4	NUM
ajmpe-262	58	17	;	;	PUNCT
ajmpe-262	58	18	july	july	PROPN
ajmpe-262	58	19	-	-	PUNCT
ajmpe-262	58	20	august	august	PROPN
ajmpe-262	58	21	2025	2025	NUM
ajmpe-262	58	22	;	;	PUNCT
ajmpe-262	58	23	issn	issn	PROPN
ajmpe-262	58	24	:	:	PUNCT
ajmpe-262	58	25	2994	2994	NUM
ajmpe-262	58	26	-	-	SYM
ajmpe-262	58	27	0524	0524	NUM
ajmpe-262	58	28	impact	impact	NOUN
ajmpe-262	58	29	factor	factor	NOUN
ajmpe-262	58	30	:	:	PUNCT
ajmpe-262	58	31	7.06	7.06	NUM
ajmpe-262	58	32	1252	1252	NUM
ajmpe-262	58	33	columbia	columbia	PROPN
ajmpe-262	58	34	rd	rd	PROPN
ajmpe-262	58	35	nw	nw	PROPN
ajmpe-262	58	36	,	,	PUNCT
ajmpe-262	58	37	washington	washington	PROPN
ajmpe-262	58	38	dc	dc	PROPN
ajmpe-262	58	39	,	,	PUNCT
ajmpe-262	58	40	united	united	PROPN
ajmpe-262	58	41	states	states	PROPN
ajmpe-262	58	42	https://topjournals.org/index.php/	https://topjournals.org/index.php/	PROPN
ajmpe-262	58	43	ajmpe	ajmpe	NOUN
ajmpe-262	58	44	;	;	PUNCT
ajmpe-262	58	45	mail	mail	NOUN
ajmpe-262	58	46	:	:	PUNCT
ajmpe-262	58	47	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-262	59	1	3	3	NUM
ajmpe-262	60	1	|	|	ADV
ajmpe-262	60	2	a	a	DET
ajmpe-262	60	3	m	m	NOUN
ajmpe-262	60	4	e	e	NOUN
ajmpe-262	60	5	r	r	NOUN
ajmpe-262	61	1	i	i	NOUN
ajmpe-262	61	2	c	c	VERB
ajmpe-262	61	3	a	a	DET
ajmpe-262	61	4	n	n	NOUN
ajmpe-262	62	1	j	j	NOUN
ajmpe-262	62	2	o	o	X
ajmpe-262	62	3	u	u	NOUN
ajmpe-262	62	4	r	r	NOUN
ajmpe-262	62	5	n	n	NOUN
ajmpe-262	62	6	a	a	DET
ajmpe-262	62	7	l	l	NOUN
ajmpe-262	62	8	o	o	X
ajmpe-262	63	1	f	f	X
ajmpe-262	63	2	m	m	NOUN
ajmpe-262	63	3	e	e	NOUN
ajmpe-262	64	1	d	d	NOUN
ajmpe-262	64	2	i	i	PRON
ajmpe-262	64	3	c	c	VERB
ajmpe-262	64	4	a	a	DET
ajmpe-262	64	5	l	l	NOUN
ajmpe-262	64	6	a	a	X
ajmpe-262	64	7	n	n	NOUN
ajmpe-262	65	1	d	d	NOUN
ajmpe-262	65	2	p	p	NOUN
ajmpe-262	65	3	h	h	NOUN
ajmpe-262	65	4	y	y	NOUN
ajmpe-262	65	5	s	s	VERB
ajmpe-262	66	1	i	i	INTJ
ajmpe-262	66	2	c	c	VERB
ajmpe-262	66	3	a	a	DET
ajmpe-262	66	4	l	l	NOUN
ajmpe-262	66	5	e	e	NOUN
ajmpe-262	66	6	d	d	X
ajmpe-262	66	7	u	u	X
ajmpe-262	66	8	c	c	PROPN
ajmpe-262	67	1	a	a	DET
ajmpe-262	67	2	t	t	NOUN
ajmpe-262	68	1	i	i	PRON
ajmpe-262	68	2	o	o	VERB
ajmpe-262	69	1	n	n	CCONJ
ajmpe-262	69	2	|	|	ADV
ajmpe-262	69	3	https://topjournals.org/index.php/	https://topjournals.org/index.php/	INTJ
ajmpe-262	69	4	ajmpe	ajmpe	NOUN
ajmpe-262	69	5	across	across	ADP
ajmpe-262	69	6	departments	department	NOUN
ajmpe-262	69	7	was	be	AUX
ajmpe-262	69	8	as	as	SCONJ
ajmpe-262	69	9	follows	follow	VERB
ajmpe-262	69	10	:	:	PUNCT
ajmpe-262	69	11	medical	medical	ADJ
ajmpe-262	69	12	laboratory	laboratory	NOUN
ajmpe-262	69	13	science	science	NOUN
ajmpe-262	69	14	(	(	PUNCT
ajmpe-262	69	15	n=11	n=11	NOUN
ajmpe-262	69	16	)	)	PUNCT
ajmpe-262	69	17	,	,	PUNCT
ajmpe-262	69	18	public	public	ADJ
ajmpe-262	69	19	health	health	NOUN
ajmpe-262	69	20	(	(	PUNCT
ajmpe-262	69	21	n=11	n=11	NOUN
ajmpe-262	69	22	)	)	PUNCT
ajmpe-262	69	23	,	,	PUNCT
ajmpe-262	69	24	dental	dental	ADJ
ajmpe-262	69	25	health	health	NOUN
ajmpe-262	69	26	(	(	PUNCT
ajmpe-262	69	27	n=12	n=12	PROPN
ajmpe-262	69	28	)	)	PUNCT
ajmpe-262	69	29	,	,	PUNCT
ajmpe-262	69	30	community	community	NOUN
ajmpe-262	69	31	health	health	NOUN
ajmpe-262	69	32	(	(	PUNCT
ajmpe-262	69	33	n=11	n=11	NOUN
ajmpe-262	69	34	)	)	PUNCT
ajmpe-262	69	35	,	,	PUNCT
ajmpe-262	69	36	health	health	NOUN
ajmpe-262	69	37	education	education	NOUN
ajmpe-262	69	38	(	(	PUNCT
ajmpe-262	69	39	n=11	n=11	NOUN
ajmpe-262	69	40	)	)	PUNCT
ajmpe-262	69	41	,	,	PUNCT
ajmpe-262	69	42	environmental	environmental	ADJ
ajmpe-262	69	43	health	health	NOUN
ajmpe-262	69	44	(	(	PUNCT
ajmpe-262	69	45	n=11	n=11	NOUN
ajmpe-262	69	46	)	)	PUNCT
ajmpe-262	69	47	,	,	PUNCT
ajmpe-262	69	48	pharmacy	pharmacy	NOUN
ajmpe-262	69	49	(	(	PUNCT
ajmpe-262	69	50	n=10	n=10	NOUN
ajmpe-262	69	51	)	)	PUNCT
ajmpe-262	69	52	,	,	PUNCT
ajmpe-262	69	53	human	human	ADJ
ajmpe-262	69	54	nutrition	nutrition	NOUN
ajmpe-262	69	55	(	(	PUNCT
ajmpe-262	69	56	n=12	n=12	NOUN
ajmpe-262	69	57	)	)	PUNCT
ajmpe-262	69	58	,	,	PUNCT
ajmpe-262	69	59	and	and	CCONJ
ajmpe-262	69	60	health	health	NOUN
ajmpe-262	69	61	information	information	NOUN
ajmpe-262	69	62	(	(	PUNCT
ajmpe-262	69	63	n=11	n=11	NOUN
ajmpe-262	69	64	)	)	PUNCT
ajmpe-262	69	65	.	.	PUNCT
ajmpe-262	70	1	ethical	ethical	ADJ
ajmpe-262	70	2	considerations	consideration	NOUN
ajmpe-262	70	3	ethical	ethical	ADJ
ajmpe-262	70	4	approval	approval	NOUN
ajmpe-262	70	5	was	be	AUX
ajmpe-262	70	6	obtained	obtain	VERB
ajmpe-262	70	7	from	from	ADP
ajmpe-262	70	8	the	the	DET
ajmpe-262	70	9	institutional	institutional	ADJ
ajmpe-262	70	10	review	review	NOUN
ajmpe-262	70	11	board	board	NOUN
ajmpe-262	70	12	of	of	ADP
ajmpe-262	70	13	kwara	kwara	PROPN
ajmpe-262	70	14	state	state	PROPN
ajmpe-262	70	15	college	college	PROPN
ajmpe-262	70	16	of	of	ADP
ajmpe-262	70	17	health	health	PROPN
ajmpe-262	70	18	technology	technology	NOUN
ajmpe-262	70	19	.	.	PUNCT
ajmpe-262	71	1	informed	informed	ADJ
ajmpe-262	71	2	consent	consent	NOUN
ajmpe-262	71	3	was	be	AUX
ajmpe-262	71	4	obtained	obtain	VERB
ajmpe-262	71	5	from	from	ADP
ajmpe-262	71	6	all	all	DET
ajmpe-262	71	7	participants	participant	NOUN
ajmpe-262	71	8	prior	prior	ADV
ajmpe-262	71	9	to	to	ADP
ajmpe-262	71	10	sample	sample	NOUN
ajmpe-262	71	11	collection	collection	NOUN
ajmpe-262	71	12	.	.	PUNCT
ajmpe-262	72	1	confidentiality	confidentiality	NOUN
ajmpe-262	72	2	of	of	ADP
ajmpe-262	72	3	all	all	DET
ajmpe-262	72	4	personal	personal	ADJ
ajmpe-262	72	5	and	and	CCONJ
ajmpe-262	72	6	medical	medical	ADJ
ajmpe-262	72	7	information	information	NOUN
ajmpe-262	72	8	was	be	AUX
ajmpe-262	72	9	maintained	maintain	VERB
ajmpe-262	72	10	throughout	throughout	ADP
ajmpe-262	72	11	the	the	DET
ajmpe-262	72	12	study	study	NOUN
ajmpe-262	72	13	.	.	PUNCT
ajmpe-262	73	1	sample	sample	NOUN
ajmpe-262	73	2	collection	collection	NOUN
ajmpe-262	73	3	and	and	CCONJ
ajmpe-262	73	4	processing	process	VERB
ajmpe-262	73	5	venous	venous	ADJ
ajmpe-262	73	6	blood	blood	NOUN
ajmpe-262	73	7	samples	sample	NOUN
ajmpe-262	73	8	(	(	PUNCT
ajmpe-262	73	9	approximately	approximately	ADV
ajmpe-262	73	10	3ml	3ml	ADJ
ajmpe-262	73	11	)	)	PUNCT
ajmpe-262	73	12	were	be	AUX
ajmpe-262	73	13	collected	collect	VERB
ajmpe-262	73	14	using	use	VERB
ajmpe-262	73	15	standard	standard	ADJ
ajmpe-262	73	16	venipuncture	venipuncture	NOUN
ajmpe-262	73	17	technique	technique	NOUN
ajmpe-262	73	18	.	.	PUNCT
ajmpe-262	74	1	blood	blood	NOUN
ajmpe-262	74	2	samples	sample	NOUN
ajmpe-262	74	3	were	be	AUX
ajmpe-262	74	4	collected	collect	VERB
ajmpe-262	74	5	in	in	ADP
ajmpe-262	74	6	plain	plain	ADJ
ajmpe-262	74	7	bottles	bottle	NOUN
ajmpe-262	74	8	and	and	CCONJ
ajmpe-262	74	9	allowed	allow	VERB
ajmpe-262	74	10	to	to	PART
ajmpe-262	74	11	clot	clot	VERB
ajmpe-262	74	12	.	.	PUNCT
ajmpe-262	75	1	sera	sera	NOUN
ajmpe-262	75	2	were	be	AUX
ajmpe-262	75	3	separated	separate	VERB
ajmpe-262	75	4	by	by	ADP
ajmpe-262	75	5	centrifugation	centrifugation	NOUN
ajmpe-262	75	6	and	and	CCONJ
ajmpe-262	75	7	stored	store	VERB
ajmpe-262	75	8	appropriately	appropriately	ADV
ajmpe-262	75	9	until	until	ADP
ajmpe-262	75	10	analysis	analysis	NOUN
ajmpe-262	75	11	.	.	PUNCT
ajmpe-262	76	1	laboratory	laboratory	NOUN
ajmpe-262	76	2	analysis	analysis	NOUN
ajmpe-262	76	3	serum	serum	NOUN
ajmpe-262	76	4	samples	sample	NOUN
ajmpe-262	76	5	were	be	AUX
ajmpe-262	76	6	screened	screen	VERB
ajmpe-262	76	7	for	for	ADP
ajmpe-262	76	8	hbsag	hbsag	NOUN
ajmpe-262	76	9	using	use	VERB
ajmpe-262	76	10	a	a	DET
ajmpe-262	76	11	commercially	commercially	ADV
ajmpe-262	76	12	available	available	ADJ
ajmpe-262	76	13	rapid	rapid	ADJ
ajmpe-262	76	14	chromatographic	chromatographic	ADJ
ajmpe-262	76	15	immunoassay	immunoassay	PROPN
ajmpe-262	76	16	kit	kit	NOUN
ajmpe-262	76	17	according	accord	VERB
ajmpe-262	76	18	to	to	ADP
ajmpe-262	76	19	the	the	DET
ajmpe-262	76	20	manufacturer	manufacturer	NOUN
ajmpe-262	76	21	's	's	PART
ajmpe-262	76	22	instructions	instruction	NOUN
ajmpe-262	76	23	.	.	PUNCT
ajmpe-262	77	1	the	the	DET
ajmpe-262	77	2	principle	principle	NOUN
ajmpe-262	77	3	of	of	ADP
ajmpe-262	77	4	the	the	DET
ajmpe-262	77	5	test	test	NOUN
ajmpe-262	77	6	is	be	AUX
ajmpe-262	77	7	based	base	VERB
ajmpe-262	77	8	on	on	ADP
ajmpe-262	77	9	the	the	DET
ajmpe-262	77	10	reaction	reaction	NOUN
ajmpe-262	77	11	between	between	ADP
ajmpe-262	77	12	specimen	speciman	NOUN
ajmpe-262	77	13	and	and	CCONJ
ajmpe-262	77	14	colloidal	colloidal	NOUN
ajmpe-262	77	15	gold	gold	NOUN
ajmpe-262	77	16	particles	particle	NOUN
ajmpe-262	77	17	labeled	label	VERB
ajmpe-262	77	18	with	with	ADP
ajmpe-262	77	19	specific	specific	ADJ
ajmpe-262	77	20	antibodies	antibody	NOUN
ajmpe-262	77	21	against	against	ADP
ajmpe-262	77	22	hbsag	hbsag	NOUN
ajmpe-262	77	23	.	.	PUNCT
ajmpe-262	78	1	a	a	DET
ajmpe-262	78	2	positive	positive	ADJ
ajmpe-262	78	3	result	result	NOUN
ajmpe-262	78	4	is	be	AUX
ajmpe-262	78	5	indicated	indicate	VERB
ajmpe-262	78	6	by	by	ADP
ajmpe-262	78	7	the	the	DET
ajmpe-262	78	8	development	development	NOUN
ajmpe-262	78	9	of	of	ADP
ajmpe-262	78	10	a	a	DET
ajmpe-262	78	11	pink	pink	ADV
ajmpe-262	78	12	-	-	PUNCT
ajmpe-262	78	13	colored	colored	ADJ
ajmpe-262	78	14	band	band	NOUN
ajmpe-262	78	15	in	in	ADP
ajmpe-262	78	16	the	the	DET
ajmpe-262	78	17	test	test	NOUN
ajmpe-262	78	18	region	region	NOUN
ajmpe-262	78	19	in	in	ADP
ajmpe-262	78	20	addition	addition	NOUN
ajmpe-262	78	21	to	to	ADP
ajmpe-262	78	22	the	the	DET
ajmpe-262	78	23	control	control	NOUN
ajmpe-262	78	24	band	band	NOUN
ajmpe-262	78	25	,	,	PUNCT
ajmpe-262	78	26	while	while	SCONJ
ajmpe-262	78	27	a	a	DET
ajmpe-262	78	28	negative	negative	ADJ
ajmpe-262	78	29	result	result	NOUN
ajmpe-262	78	30	shows	show	VERB
ajmpe-262	78	31	only	only	ADV
ajmpe-262	78	32	the	the	DET
ajmpe-262	78	33	control	control	NOUN
ajmpe-262	78	34	band	band	NOUN
ajmpe-262	78	35	.	.	PUNCT
ajmpe-262	79	1	quality	quality	NOUN
ajmpe-262	79	2	control	control	NOUN
ajmpe-262	79	3	measures	measure	NOUN
ajmpe-262	79	4	included	include	VERB
ajmpe-262	79	5	checking	check	VERB
ajmpe-262	79	6	expiration	expiration	NOUN
ajmpe-262	79	7	dates	date	NOUN
ajmpe-262	79	8	of	of	ADP
ajmpe-262	79	9	test	test	NOUN
ajmpe-262	79	10	kits	kit	NOUN
ajmpe-262	79	11	,	,	PUNCT
ajmpe-262	79	12	ensuring	ensure	VERB
ajmpe-262	79	13	water	water	NOUN
ajmpe-262	79	14	-	-	PUNCT
ajmpe-262	79	15	free	free	ADJ
ajmpe-262	79	16	conditions	condition	NOUN
ajmpe-262	79	17	,	,	PUNCT
ajmpe-262	79	18	avoiding	avoid	VERB
ajmpe-262	79	19	sample	sample	NOUN
ajmpe-262	79	20	mix	mix	NOUN
ajmpe-262	79	21	-	-	PUNCT
ajmpe-262	79	22	ups	up	NOUN
ajmpe-262	79	23	,	,	PUNCT
ajmpe-262	79	24	and	and	CCONJ
ajmpe-262	79	25	running	run	VERB
ajmpe-262	79	26	positive	positive	ADJ
ajmpe-262	79	27	and	and	CCONJ
ajmpe-262	79	28	negative	negative	ADJ
ajmpe-262	79	29	controls	control	NOUN
ajmpe-262	79	30	with	with	ADP
ajmpe-262	79	31	each	each	DET
ajmpe-262	79	32	batch	batch	NOUN
ajmpe-262	79	33	of	of	ADP
ajmpe-262	79	34	tests	test	NOUN
ajmpe-262	79	35	.	.	PUNCT
ajmpe-262	80	1	data	datum	NOUN
ajmpe-262	80	2	analysis	analysis	NOUN
ajmpe-262	80	3	data	datum	NOUN
ajmpe-262	80	4	were	be	AUX
ajmpe-262	80	5	analyzed	analyze	VERB
ajmpe-262	80	6	using	use	VERB
ajmpe-262	80	7	simple	simple	ADJ
ajmpe-262	80	8	descriptive	descriptive	ADJ
ajmpe-262	80	9	statistics	statistic	NOUN
ajmpe-262	80	10	.	.	PUNCT
ajmpe-262	81	1	the	the	DET
ajmpe-262	81	2	prevalence	prevalence	NOUN
ajmpe-262	81	3	of	of	ADP
ajmpe-262	81	4	hbsag	hbsag	NOUN
ajmpe-262	81	5	was	be	AUX
ajmpe-262	81	6	calculated	calculate	VERB
ajmpe-262	81	7	as	as	SCONJ
ajmpe-262	81	8	the	the	DET
ajmpe-262	81	9	percentage	percentage	NOUN
ajmpe-262	81	10	of	of	ADP
ajmpe-262	81	11	positive	positive	ADJ
ajmpe-262	81	12	cases	case	NOUN
ajmpe-262	81	13	among	among	ADP
ajmpe-262	81	14	the	the	DET
ajmpe-262	81	15	total	total	ADJ
ajmpe-262	81	16	number	number	NOUN
ajmpe-262	81	17	of	of	ADP
ajmpe-262	81	18	students	student	NOUN
ajmpe-262	81	19	tested	test	VERB
ajmpe-262	81	20	.	.	PUNCT
ajmpe-262	82	1	stratified	stratify	VERB
ajmpe-262	82	2	analysis	analysis	NOUN
ajmpe-262	82	3	was	be	AUX
ajmpe-262	82	4	performed	perform	VERB
ajmpe-262	82	5	to	to	PART
ajmpe-262	82	6	determine	determine	VERB
ajmpe-262	82	7	the	the	DET
ajmpe-262	82	8	distribution	distribution	NOUN
ajmpe-262	82	9	of	of	ADP
ajmpe-262	82	10	hbsag	hbsag	ADJ
ajmpe-262	82	11	positivity	positivity	NOUN
ajmpe-262	82	12	by	by	ADP
ajmpe-262	82	13	age	age	NOUN
ajmpe-262	82	14	,	,	PUNCT
ajmpe-262	82	15	sex	sex	NOUN
ajmpe-262	82	16	,	,	PUNCT
ajmpe-262	82	17	and	and	CCONJ
ajmpe-262	82	18	department	department	NOUN
ajmpe-262	82	19	.	.	PUNCT
ajmpe-262	83	1	results	result	VERB
ajmpe-262	83	2	overall	overall	ADJ
ajmpe-262	83	3	prevalence	prevalence	NOUN
ajmpe-262	83	4	of	of	ADP
ajmpe-262	83	5	hbsag	hbsag	NOUN
ajmpe-262	83	6	of	of	ADP
ajmpe-262	83	7	the	the	DET
ajmpe-262	83	8	100	100	NUM
ajmpe-262	83	9	students	student	NOUN
ajmpe-262	83	10	screened	screen	VERB
ajmpe-262	83	11	,	,	PUNCT
ajmpe-262	83	12	7	7	NUM
ajmpe-262	83	13	tested	test	VERB
ajmpe-262	83	14	positive	positive	ADJ
ajmpe-262	83	15	for	for	ADP
ajmpe-262	83	16	hbsag	hbsag	NOUN
ajmpe-262	83	17	,	,	PUNCT
ajmpe-262	83	18	giving	give	VERB
ajmpe-262	83	19	an	an	DET
ajmpe-262	83	20	overall	overall	ADJ
ajmpe-262	83	21	seroprevalence	seroprevalence	NOUN
ajmpe-262	83	22	of	of	ADP
ajmpe-262	83	23	7	7	NUM
ajmpe-262	83	24	%	%	NOUN
ajmpe-262	83	25	.	.	PUNCT
ajmpe-262	84	1	prevalence	prevalence	NOUN
ajmpe-262	84	2	of	of	ADP
ajmpe-262	84	3	hbsag	hbsag	NOUN
ajmpe-262	84	4	by	by	ADP
ajmpe-262	84	5	sex	sex	NOUN
ajmpe-262	84	6	among	among	ADP
ajmpe-262	84	7	the	the	DET
ajmpe-262	84	8	39	39	NUM
ajmpe-262	84	9	males	male	NOUN
ajmpe-262	84	10	screened	screen	VERB
ajmpe-262	84	11	,	,	PUNCT
ajmpe-262	84	12	2	2	NUM
ajmpe-262	84	13	(	(	PUNCT
ajmpe-262	84	14	5.13	5.13	NUM
ajmpe-262	84	15	%	%	NOUN
ajmpe-262	84	16	)	)	PUNCT
ajmpe-262	84	17	were	be	AUX
ajmpe-262	84	18	positive	positive	ADJ
ajmpe-262	84	19	for	for	ADP
ajmpe-262	84	20	hbsag	hbsag	NOUN
ajmpe-262	84	21	,	,	PUNCT
ajmpe-262	84	22	while	while	SCONJ
ajmpe-262	84	23	5	5	NUM
ajmpe-262	84	24	of	of	ADP
ajmpe-262	84	25	the	the	DET
ajmpe-262	84	26	61	61	NUM
ajmpe-262	84	27	females	female	NOUN
ajmpe-262	84	28	(	(	PUNCT
ajmpe-262	84	29	8.2	8.2	NUM
ajmpe-262	84	30	%	%	NOUN
ajmpe-262	84	31	)	)	PUNCT
ajmpe-262	84	32	tested	test	VERB
ajmpe-262	84	33	positive	positive	ADJ
ajmpe-262	84	34	(	(	PUNCT
ajmpe-262	84	35	figure	figure	NOUN
ajmpe-262	84	36	1	1	NUM
ajmpe-262	84	37	)	)	PUNCT
ajmpe-262	84	38	.	.	PUNCT
ajmpe-262	85	1	the	the	DET
ajmpe-262	85	2	data	datum	NOUN
ajmpe-262	85	3	indicated	indicate	VERB
ajmpe-262	85	4	a	a	DET
ajmpe-262	85	5	higher	high	ADJ
ajmpe-262	85	6	seroprevalence	seroprevalence	NOUN
ajmpe-262	85	7	among	among	ADP
ajmpe-262	85	8	female	female	ADJ
ajmpe-262	85	9	students	student	NOUN
ajmpe-262	85	10	compared	compare	VERB
ajmpe-262	85	11	to	to	ADP
ajmpe-262	85	12	their	their	PRON
ajmpe-262	85	13	male	male	ADJ
ajmpe-262	85	14	counterparts	counterpart	NOUN
ajmpe-262	85	15	.	.	PUNCT
ajmpe-262	86	1	prevalence	prevalence	NOUN
ajmpe-262	86	2	of	of	ADP
ajmpe-262	86	3	hbsag	hbsag	NOUN
ajmpe-262	86	4	by	by	ADP
ajmpe-262	86	5	age	age	NOUN
ajmpe-262	86	6	group	group	NOUN
ajmpe-262	86	7	the	the	DET
ajmpe-262	86	8	age	age	NOUN
ajmpe-262	86	9	-	-	PUNCT
ajmpe-262	86	10	specific	specific	ADJ
ajmpe-262	86	11	distribution	distribution	NOUN
ajmpe-262	86	12	of	of	ADP
ajmpe-262	86	13	hbsag	hbsag	NOUN
ajmpe-262	86	14	showed	show	VERB
ajmpe-262	86	15	that	that	SCONJ
ajmpe-262	86	16	students	student	NOUN
ajmpe-262	86	17	in	in	ADP
ajmpe-262	86	18	the	the	DET
ajmpe-262	86	19	age	age	NOUN
ajmpe-262	86	20	group	group	NOUN
ajmpe-262	86	21	18	18	NUM
ajmpe-262	86	22	-	-	SYM
ajmpe-262	86	23	21	21	NUM
ajmpe-262	86	24	years	year	NOUN
ajmpe-262	86	25	had	have	VERB
ajmpe-262	86	26	the	the	DET
ajmpe-262	86	27	highest	high	ADJ
ajmpe-262	86	28	prevalence	prevalence	NOUN
ajmpe-262	86	29	rate	rate	NOUN
ajmpe-262	86	30	of	of	ADP
ajmpe-262	86	31	12.5	12.5	NUM
ajmpe-262	86	32	%	%	NOUN
ajmpe-262	86	33	(	(	PUNCT
ajmpe-262	86	34	5/40	5/40	NUM
ajmpe-262	86	35	)	)	PUNCT
ajmpe-262	86	36	,	,	PUNCT
ajmpe-262	86	37	followed	follow	VERB
ajmpe-262	86	38	by	by	ADP
ajmpe-262	86	39	those	those	PRON
ajmpe-262	86	40	in	in	ADP
ajmpe-262	86	41	the	the	DET
ajmpe-262	86	42	age	age	NOUN
ajmpe-262	86	43	group	group	NOUN
ajmpe-262	86	44	22	22	NUM
ajmpe-262	86	45	-	-	SYM
ajmpe-262	86	46	25	25	NUM
ajmpe-262	86	47	years	year	NOUN
ajmpe-262	86	48	with	with	ADP
ajmpe-262	86	49	a	a	DET
ajmpe-262	86	50	prevalence	prevalence	NOUN
ajmpe-262	86	51	of	of	ADP
ajmpe-262	86	52	4	4	NUM
ajmpe-262	86	53	%	%	NOUN
ajmpe-262	86	54	(	(	PUNCT
ajmpe-262	86	55	2/50	2/50	NUM
ajmpe-262	86	56	)	)	PUNCT
ajmpe-262	86	57	.	.	PUNCT
ajmpe-262	87	1	no	no	DET
ajmpe-262	87	2	positive	positive	ADJ
ajmpe-262	87	3	cases	case	NOUN
ajmpe-262	87	4	were	be	AUX
ajmpe-262	87	5	detected	detect	VERB
ajmpe-262	87	6	among	among	ADP
ajmpe-262	87	7	students	student	NOUN
ajmpe-262	87	8	aged	age	VERB
ajmpe-262	87	9	26	26	NUM
ajmpe-262	87	10	years	year	NOUN
ajmpe-262	87	11	and	and	CCONJ
ajmpe-262	87	12	above	above	ADV
ajmpe-262	87	13	(	(	PUNCT
ajmpe-262	87	14	0/10	0/10	NUM
ajmpe-262	87	15	)	)	PUNCT
ajmpe-262	87	16	(	(	PUNCT
ajmpe-262	87	17	figure	figure	NOUN
ajmpe-262	87	18	2	2	NUM
ajmpe-262	87	19	)	)	PUNCT
ajmpe-262	87	20	.	.	PUNCT
ajmpe-262	88	1	prevalence	prevalence	NOUN
ajmpe-262	88	2	of	of	ADP
ajmpe-262	88	3	hbsag	hbsag	NOUN
ajmpe-262	88	4	by	by	ADP
ajmpe-262	88	5	department	department	PROPN
ajmpe-262	88	6	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-262	88	7	american	american	PROPN
ajmpe-262	88	8	journal	journal	PROPN
ajmpe-262	88	9	of	of	ADP
ajmpe-262	88	10	medical	medical	ADJ
ajmpe-262	88	11	and	and	CCONJ
ajmpe-262	88	12	physical	physical	ADJ
ajmpe-262	88	13	education	education	NOUN
ajmpe-262	88	14	vol.10	vol.10	NOUN
ajmpe-262	88	15	,	,	PUNCT
ajmpe-262	88	16	issue	issue	NOUN
ajmpe-262	88	17	4	4	NUM
ajmpe-262	88	18	;	;	PUNCT
ajmpe-262	88	19	july	july	PROPN
ajmpe-262	88	20	-	-	PUNCT
ajmpe-262	88	21	august	august	PROPN
ajmpe-262	88	22	2025	2025	NUM
ajmpe-262	88	23	;	;	PUNCT
ajmpe-262	88	24	issn	issn	PROPN
ajmpe-262	88	25	:	:	PUNCT
ajmpe-262	88	26	2994	2994	NUM
ajmpe-262	88	27	-	-	SYM
ajmpe-262	88	28	0524	0524	NUM
ajmpe-262	88	29	impact	impact	NOUN
ajmpe-262	88	30	factor	factor	NOUN
ajmpe-262	88	31	:	:	PUNCT
ajmpe-262	88	32	7.06	7.06	NUM
ajmpe-262	88	33	1252	1252	NUM
ajmpe-262	88	34	columbia	columbia	PROPN
ajmpe-262	88	35	rd	rd	PROPN
ajmpe-262	88	36	nw	nw	PROPN
ajmpe-262	88	37	,	,	PUNCT
ajmpe-262	88	38	washington	washington	PROPN
ajmpe-262	88	39	dc	dc	PROPN
ajmpe-262	88	40	,	,	PUNCT
ajmpe-262	88	41	united	united	PROPN
ajmpe-262	88	42	states	states	PROPN
ajmpe-262	88	43	https://topjournals.org/index.php/	https://topjournals.org/index.php/	PROPN
ajmpe-262	88	44	ajmpe	ajmpe	NOUN
ajmpe-262	88	45	;	;	PUNCT
ajmpe-262	88	46	mail	mail	NOUN
ajmpe-262	88	47	:	:	PUNCT
ajmpe-262	88	48	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-262	89	1	4	4	NUM
ajmpe-262	89	2	|	|	ADV
ajmpe-262	89	3	a	a	DET
ajmpe-262	89	4	m	m	NOUN
ajmpe-262	89	5	e	e	NOUN
ajmpe-262	89	6	r	r	NOUN
ajmpe-262	90	1	i	i	NOUN
ajmpe-262	90	2	c	c	VERB
ajmpe-262	90	3	a	a	DET
ajmpe-262	90	4	n	n	NOUN
ajmpe-262	91	1	j	j	NOUN
ajmpe-262	91	2	o	o	X
ajmpe-262	91	3	u	u	NOUN
ajmpe-262	91	4	r	r	NOUN
ajmpe-262	91	5	n	n	NOUN
ajmpe-262	91	6	a	a	DET
ajmpe-262	91	7	l	l	NOUN
ajmpe-262	91	8	o	o	X
ajmpe-262	92	1	f	f	X
ajmpe-262	92	2	m	m	NOUN
ajmpe-262	92	3	e	e	NOUN
ajmpe-262	93	1	d	d	NOUN
ajmpe-262	93	2	i	i	PRON
ajmpe-262	93	3	c	c	VERB
ajmpe-262	93	4	a	a	DET
ajmpe-262	93	5	l	l	NOUN
ajmpe-262	93	6	a	a	X
ajmpe-262	93	7	n	n	NOUN
ajmpe-262	94	1	d	d	NOUN
ajmpe-262	94	2	p	p	NOUN
ajmpe-262	94	3	h	h	NOUN
ajmpe-262	94	4	y	y	NOUN
ajmpe-262	94	5	s	s	VERB
ajmpe-262	95	1	i	i	INTJ
ajmpe-262	95	2	c	c	VERB
ajmpe-262	95	3	a	a	DET
ajmpe-262	95	4	l	l	NOUN
ajmpe-262	95	5	e	e	NOUN
ajmpe-262	95	6	d	d	X
ajmpe-262	95	7	u	u	X
ajmpe-262	95	8	c	c	PROPN
ajmpe-262	96	1	a	a	DET
ajmpe-262	96	2	t	t	NOUN
ajmpe-262	97	1	i	i	PRON
ajmpe-262	97	2	o	o	VERB
ajmpe-262	98	1	n	n	CCONJ
ajmpe-262	98	2	|	|	ADV
ajmpe-262	98	3	https://topjournals.org/index.php/	https://topjournals.org/index.php/	INTJ
ajmpe-262	98	4	ajmpe	ajmpe	VERB
ajmpe-262	98	5	the	the	DET
ajmpe-262	98	6	departmental	departmental	ADJ
ajmpe-262	98	7	distribution	distribution	NOUN
ajmpe-262	98	8	of	of	ADP
ajmpe-262	98	9	hbsag	hbsag	ADJ
ajmpe-262	98	10	positivity	positivity	NOUN
ajmpe-262	98	11	revealed	reveal	VERB
ajmpe-262	98	12	that	that	SCONJ
ajmpe-262	98	13	students	student	NOUN
ajmpe-262	98	14	from	from	ADP
ajmpe-262	98	15	the	the	DET
ajmpe-262	98	16	environmental	environmental	PROPN
ajmpe-262	98	17	health	health	PROPN
ajmpe-262	98	18	department	department	PROPN
ajmpe-262	98	19	had	have	VERB
ajmpe-262	98	20	the	the	DET
ajmpe-262	98	21	highest	high	ADJ
ajmpe-262	98	22	prevalence	prevalence	NOUN
ajmpe-262	98	23	at	at	ADP
ajmpe-262	98	24	27.1	27.1	NUM
ajmpe-262	98	25	%	%	NOUN
ajmpe-262	98	26	(	(	PUNCT
ajmpe-262	98	27	3/11	3/11	NUM
ajmpe-262	98	28	)	)	PUNCT
ajmpe-262	98	29	,	,	PUNCT
ajmpe-262	98	30	followed	follow	VERB
ajmpe-262	98	31	by	by	ADP
ajmpe-262	98	32	public	public	ADJ
ajmpe-262	98	33	health	health	NOUN
ajmpe-262	98	34	and	and	CCONJ
ajmpe-262	98	35	community	community	NOUN
ajmpe-262	98	36	health	health	NOUN
ajmpe-262	98	37	departments	department	NOUN
ajmpe-262	98	38	,	,	PUNCT
ajmpe-262	98	39	each	each	PRON
ajmpe-262	98	40	with	with	ADP
ajmpe-262	98	41	9.1	9.1	NUM
ajmpe-262	98	42	%	%	NOUN
ajmpe-262	98	43	(	(	PUNCT
ajmpe-262	98	44	1/11	1/11	NUM
ajmpe-262	98	45	)	)	PUNCT
ajmpe-262	98	46	.	.	PUNCT
ajmpe-262	99	1	dental	dental	ADJ
ajmpe-262	99	2	health	health	NOUN
ajmpe-262	99	3	and	and	CCONJ
ajmpe-262	99	4	nutrition	nutrition	NOUN
ajmpe-262	99	5	departments	department	NOUN
ajmpe-262	99	6	each	each	PRON
ajmpe-262	99	7	had	have	VERB
ajmpe-262	99	8	a	a	DET
ajmpe-262	99	9	prevalence	prevalence	NOUN
ajmpe-262	99	10	of	of	ADP
ajmpe-262	99	11	8.3	8.3	NUM
ajmpe-262	99	12	%	%	NOUN
ajmpe-262	99	13	(	(	PUNCT
ajmpe-262	99	14	1/12	1/12	NUM
ajmpe-262	99	15	)	)	PUNCT
ajmpe-262	99	16	.	.	PUNCT
ajmpe-262	100	1	no	no	DET
ajmpe-262	100	2	positive	positive	ADJ
ajmpe-262	100	3	cases	case	NOUN
ajmpe-262	100	4	were	be	AUX
ajmpe-262	100	5	detected	detect	VERB
ajmpe-262	100	6	among	among	ADP
ajmpe-262	100	7	students	student	NOUN
ajmpe-262	100	8	from	from	ADP
ajmpe-262	100	9	medical	medical	ADJ
ajmpe-262	100	10	laboratory	laboratory	NOUN
ajmpe-262	100	11	science	science	NOUN
ajmpe-262	100	12	,	,	PUNCT
ajmpe-262	100	13	health	health	NOUN
ajmpe-262	100	14	education	education	NOUN
ajmpe-262	100	15	,	,	PUNCT
ajmpe-262	100	16	pharmacy	pharmacy	NOUN
ajmpe-262	100	17	,	,	PUNCT
ajmpe-262	100	18	and	and	CCONJ
ajmpe-262	100	19	health	health	NOUN
ajmpe-262	100	20	information	information	NOUN
ajmpe-262	100	21	departments	department	NOUN
ajmpe-262	100	22	(	(	PUNCT
ajmpe-262	100	23	figure	figure	NOUN
ajmpe-262	100	24	3	3	NUM
ajmpe-262	100	25	)	)	PUNCT
ajmpe-262	100	26	.	.	PUNCT
ajmpe-262	101	1	discussion	discussion	NOUN
ajmpe-262	101	2	this	this	DET
ajmpe-262	101	3	study	study	NOUN
ajmpe-262	101	4	reports	report	VERB
ajmpe-262	101	5	an	an	DET
ajmpe-262	101	6	overall	overall	ADJ
ajmpe-262	101	7	hbsag	hbsag	ADJ
ajmpe-262	101	8	seroprevalence	seroprevalence	NOUN
ajmpe-262	101	9	of	of	ADP
ajmpe-262	101	10	7	7	NUM
ajmpe-262	101	11	%	%	NOUN
ajmpe-262	101	12	among	among	ADP
ajmpe-262	101	13	students	student	NOUN
ajmpe-262	101	14	of	of	ADP
ajmpe-262	101	15	kwara	kwara	PROPN
ajmpe-262	101	16	state	state	PROPN
ajmpe-262	101	17	college	college	PROPN
ajmpe-262	101	18	of	of	ADP
ajmpe-262	101	19	health	health	PROPN
ajmpe-262	101	20	technology	technology	NOUN
ajmpe-262	101	21	,	,	PUNCT
ajmpe-262	101	22	offa	offa	NOUN
ajmpe-262	101	23	,	,	PUNCT
ajmpe-262	101	24	nigeria	nigeria	PROPN
ajmpe-262	101	25	.	.	PUNCT
ajmpe-262	102	1	this	this	DET
ajmpe-262	102	2	finding	finding	NOUN
ajmpe-262	102	3	falls	fall	VERB
ajmpe-262	102	4	within	within	ADP
ajmpe-262	102	5	the	the	DET
ajmpe-262	102	6	range	range	NOUN
ajmpe-262	102	7	of	of	ADP
ajmpe-262	102	8	hbsag	hbsag	ADJ
ajmpe-262	102	9	prevalence	prevalence	NOUN
ajmpe-262	102	10	reported	report	VERB
ajmpe-262	102	11	in	in	ADP
ajmpe-262	102	12	previous	previous	ADJ
ajmpe-262	102	13	studies	study	NOUN
ajmpe-262	102	14	conducted	conduct	VERB
ajmpe-262	102	15	in	in	ADP
ajmpe-262	102	16	nigeria	nigeria	PROPN
ajmpe-262	102	17	,	,	PUNCT
ajmpe-262	102	18	which	which	PRON
ajmpe-262	102	19	varies	vary	VERB
ajmpe-262	102	20	between	between	ADP
ajmpe-262	102	21	2	2	NUM
ajmpe-262	102	22	%	%	NOUN
ajmpe-262	102	23	and	and	CCONJ
ajmpe-262	102	24	20	20	NUM
ajmpe-262	102	25	%	%	NOUN
ajmpe-262	102	26	depending	depend	VERB
ajmpe-262	102	27	on	on	ADP
ajmpe-262	102	28	the	the	DET
ajmpe-262	102	29	population	population	NOUN
ajmpe-262	102	30	and	and	CCONJ
ajmpe-262	102	31	geographical	geographical	ADJ
ajmpe-262	102	32	region	region	NOUN
ajmpe-262	102	33	(	(	PUNCT
ajmpe-262	102	34	musa	musa	PROPN
ajmpe-262	102	35	et	et	PROPN
ajmpe-262	102	36	al	al	PROPN
ajmpe-262	102	37	.	.	PROPN
ajmpe-262	102	38	,	,	PUNCT
ajmpe-262	102	39	2015	2015	NUM
ajmpe-262	102	40	;	;	PUNCT
ajmpe-262	102	41	eke	eke	VERB
ajmpe-262	102	42	et	et	PROPN
ajmpe-262	102	43	al	al	PROPN
ajmpe-262	102	44	.	.	PROPN
ajmpe-262	102	45	,	,	PUNCT
ajmpe-262	102	46	2011	2011	NUM
ajmpe-262	102	47	)	)	PUNCT
ajmpe-262	102	48	.	.	PUNCT
ajmpe-262	103	1	according	accord	VERB
ajmpe-262	103	2	to	to	ADP
ajmpe-262	103	3	the	the	DET
ajmpe-262	103	4	world	world	PROPN
ajmpe-262	103	5	health	health	NOUN
ajmpe-262	103	6	organization	organization	PROPN
ajmpe-262	103	7	classification	classification	NOUN
ajmpe-262	103	8	of	of	ADP
ajmpe-262	103	9	hbv	hbv	NOUN
ajmpe-262	103	10	endemicity	endemicity	NOUN
ajmpe-262	103	11	,	,	PUNCT
ajmpe-262	103	12	a	a	DET
ajmpe-262	103	13	prevalence	prevalence	NOUN
ajmpe-262	103	14	of	of	ADP
ajmpe-262	103	15	7	7	NUM
ajmpe-262	103	16	%	%	NOUN
ajmpe-262	103	17	places	place	NOUN
ajmpe-262	103	18	this	this	DET
ajmpe-262	103	19	population	population	NOUN
ajmpe-262	103	20	in	in	ADP
ajmpe-262	103	21	the	the	DET
ajmpe-262	103	22	intermediate	intermediate	ADJ
ajmpe-262	103	23	-	-	PUNCT
ajmpe-262	103	24	high	high	ADJ
ajmpe-262	103	25	endemicity	endemicity	NOUN
ajmpe-262	103	26	category	category	NOUN
ajmpe-262	103	27	(	(	PUNCT
ajmpe-262	103	28	5	5	NUM
ajmpe-262	103	29	-	-	SYM
ajmpe-262	103	30	7	7	NUM
ajmpe-262	103	31	%	%	NOUN
ajmpe-262	103	32	)	)	PUNCT
ajmpe-262	103	33	,	,	PUNCT
ajmpe-262	103	34	which	which	PRON
ajmpe-262	103	35	is	be	AUX
ajmpe-262	103	36	consistent	consistent	ADJ
ajmpe-262	103	37	with	with	ADP
ajmpe-262	103	38	the	the	DET
ajmpe-262	103	39	general	general	ADJ
ajmpe-262	103	40	classification	classification	NOUN
ajmpe-262	103	41	of	of	ADP
ajmpe-262	103	42	nigeria	nigeria	PROPN
ajmpe-262	103	43	as	as	ADP
ajmpe-262	103	44	an	an	DET
ajmpe-262	103	45	hbv	hbv	NOUN
ajmpe-262	103	46	endemic	endemic	ADJ
ajmpe-262	103	47	country	country	NOUN
ajmpe-262	103	48	(	(	PUNCT
ajmpe-262	103	49	who	who	PRON
ajmpe-262	103	50	,	,	PUNCT
ajmpe-262	103	51	2022	2022	NUM
ajmpe-262	103	52	)	)	PUNCT
ajmpe-262	103	53	.	.	PUNCT
ajmpe-262	104	1	the	the	DET
ajmpe-262	104	2	result	result	NOUN
ajmpe-262	104	3	is	be	AUX
ajmpe-262	104	4	comparable	comparable	ADJ
ajmpe-262	104	5	to	to	ADP
ajmpe-262	104	6	findings	finding	NOUN
ajmpe-262	104	7	from	from	ADP
ajmpe-262	104	8	similar	similar	ADJ
ajmpe-262	104	9	studies	study	NOUN
ajmpe-262	104	10	among	among	ADP
ajmpe-262	104	11	college	college	NOUN
ajmpe-262	104	12	students	student	NOUN
ajmpe-262	104	13	in	in	ADP
ajmpe-262	104	14	nigeria	nigeria	PROPN
ajmpe-262	104	15	,	,	PUNCT
ajmpe-262	104	16	such	such	ADJ
ajmpe-262	104	17	as	as	ADP
ajmpe-262	104	18	the	the	DET
ajmpe-262	104	19	6.2	6.2	NUM
ajmpe-262	104	20	%	%	NOUN
ajmpe-262	104	21	prevalence	prevalence	NOUN
ajmpe-262	104	22	reported	report	VERB
ajmpe-262	104	23	by	by	ADP
ajmpe-262	104	24	oluboyo	oluboyo	NOUN
ajmpe-262	104	25	et	et	PROPN
ajmpe-262	104	26	al	al	PROPN
ajmpe-262	104	27	.	.	PROPN
ajmpe-262	105	1	(	(	PUNCT
ajmpe-262	105	2	2014	2014	NUM
ajmpe-262	105	3	)	)	PUNCT
ajmpe-262	105	4	among	among	ADP
ajmpe-262	105	5	students	student	NOUN
ajmpe-262	105	6	in	in	ADP
ajmpe-262	105	7	ekiti	ekiti	ADJ
ajmpe-262	105	8	state	state	NOUN
ajmpe-262	105	9	and	and	CCONJ
ajmpe-262	105	10	8.3	8.3	NUM
ajmpe-262	105	11	%	%	NOUN
ajmpe-262	105	12	reported	report	VERB
ajmpe-262	105	13	by	by	ADP
ajmpe-262	105	14	ndako	ndako	PROPN
ajmpe-262	105	15	et	et	PROPN
ajmpe-262	105	16	al	al	PROPN
ajmpe-262	105	17	.	.	PROPN
ajmpe-262	106	1	(	(	PUNCT
ajmpe-262	106	2	2013	2013	NUM
ajmpe-262	106	3	)	)	PUNCT
ajmpe-262	106	4	among	among	ADP
ajmpe-262	106	5	students	student	NOUN
ajmpe-262	106	6	in	in	ADP
ajmpe-262	106	7	ibadan	ibadan	PROPN
ajmpe-262	106	8	.	.	PUNCT
ajmpe-262	107	1	the	the	DET
ajmpe-262	107	2	higher	high	ADJ
ajmpe-262	107	3	prevalence	prevalence	NOUN
ajmpe-262	107	4	of	of	ADP
ajmpe-262	107	5	hbsag	hbsag	NOUN
ajmpe-262	107	6	among	among	ADP
ajmpe-262	107	7	female	female	ADJ
ajmpe-262	107	8	students	student	NOUN
ajmpe-262	107	9	(	(	PUNCT
ajmpe-262	107	10	8.2	8.2	NUM
ajmpe-262	107	11	%	%	NOUN
ajmpe-262	107	12	)	)	PUNCT
ajmpe-262	107	13	compared	compare	VERB
ajmpe-262	107	14	to	to	ADP
ajmpe-262	107	15	male	male	ADJ
ajmpe-262	107	16	students	student	NOUN
ajmpe-262	107	17	(	(	PUNCT
ajmpe-262	107	18	5.13	5.13	NUM
ajmpe-262	107	19	%	%	NOUN
ajmpe-262	107	20	)	)	PUNCT
ajmpe-262	107	21	observed	observe	VERB
ajmpe-262	107	22	in	in	ADP
ajmpe-262	107	23	this	this	DET
ajmpe-262	107	24	study	study	NOUN
ajmpe-262	107	25	contrasts	contrast	VERB
ajmpe-262	107	26	with	with	ADP
ajmpe-262	107	27	several	several	ADJ
ajmpe-262	107	28	previous	previous	ADJ
ajmpe-262	107	29	studies	study	NOUN
ajmpe-262	107	30	that	that	PRON
ajmpe-262	107	31	reported	report	VERB
ajmpe-262	107	32	higher	high	ADJ
ajmpe-262	107	33	prevalence	prevalence	NOUN
ajmpe-262	107	34	among	among	ADP
ajmpe-262	107	35	males	male	NOUN
ajmpe-262	107	36	(	(	PUNCT
ajmpe-262	107	37	eke	eke	ADJ
ajmpe-262	107	38	et	et	PROPN
ajmpe-262	107	39	al	al	PROPN
ajmpe-262	107	40	.	.	PROPN
ajmpe-262	107	41	,	,	PUNCT
ajmpe-262	107	42	2011	2011	NUM
ajmpe-262	107	43	;	;	PUNCT
ajmpe-262	107	44	ndako	ndako	PROPN
ajmpe-262	107	45	et	et	PROPN
ajmpe-262	107	46	al	al	PROPN
ajmpe-262	107	47	.	.	PROPN
ajmpe-262	107	48	,	,	PUNCT
ajmpe-262	107	49	2013	2013	NUM
ajmpe-262	107	50	)	)	PUNCT
ajmpe-262	107	51	.	.	PUNCT
ajmpe-262	108	1	this	this	DET
ajmpe-262	108	2	unusual	unusual	ADJ
ajmpe-262	108	3	finding	finding	NOUN
ajmpe-262	108	4	may	may	AUX
ajmpe-262	108	5	be	be	AUX
ajmpe-262	108	6	attributed	attribute	VERB
ajmpe-262	108	7	to	to	ADP
ajmpe-262	108	8	the	the	DET
ajmpe-262	108	9	unequal	unequal	ADJ
ajmpe-262	108	10	distribution	distribution	NOUN
ajmpe-262	108	11	of	of	ADP
ajmpe-262	108	12	participants	participant	NOUN
ajmpe-262	108	13	by	by	ADP
ajmpe-262	108	14	sex	sex	NOUN
ajmpe-262	108	15	in	in	ADP
ajmpe-262	108	16	our	our	PRON
ajmpe-262	108	17	study	study	NOUN
ajmpe-262	108	18	(	(	PUNCT
ajmpe-262	108	19	61	61	NUM
ajmpe-262	108	20	females	female	NOUN
ajmpe-262	108	21	vs.	vs.	ADP
ajmpe-262	108	22	39	39	NUM
ajmpe-262	108	23	males	male	NOUN
ajmpe-262	108	24	)	)	PUNCT
ajmpe-262	108	25	or	or	CCONJ
ajmpe-262	108	26	could	could	AUX
ajmpe-262	108	27	reflect	reflect	VERB
ajmpe-262	108	28	local	local	ADJ
ajmpe-262	108	29	epidemiological	epidemiological	ADJ
ajmpe-262	108	30	patterns	pattern	NOUN
ajmpe-262	108	31	.	.	PUNCT
ajmpe-262	109	1	potential	potential	ADJ
ajmpe-262	109	2	factors	factor	NOUN
ajmpe-262	109	3	contributing	contribute	VERB
ajmpe-262	109	4	to	to	ADP
ajmpe-262	109	5	higher	high	ADJ
ajmpe-262	109	6	female	female	ADJ
ajmpe-262	109	7	prevalence	prevalence	NOUN
ajmpe-262	109	8	might	might	AUX
ajmpe-262	109	9	include	include	VERB
ajmpe-262	109	10	higher	high	ADJ
ajmpe-262	109	11	rates	rate	NOUN
ajmpe-262	109	12	of	of	ADP
ajmpe-262	109	13	body	body	NOUN
ajmpe-262	109	14	enhancement	enhancement	NOUN
ajmpe-262	109	15	procedures	procedure	NOUN
ajmpe-262	109	16	such	such	ADJ
ajmpe-262	109	17	as	as	ADP
ajmpe-262	109	18	manicure	manicure	NOUN
ajmpe-262	109	19	/	/	SYM
ajmpe-262	109	20	pedicure	pedicure	NOUN
ajmpe-262	109	21	with	with	ADP
ajmpe-262	109	22	shared	share	VERB
ajmpe-262	109	23	instruments	instrument	NOUN
ajmpe-262	109	24	,	,	PUNCT
ajmpe-262	109	25	or	or	CCONJ
ajmpe-262	109	26	other	other	ADJ
ajmpe-262	109	27	gender	gender	NOUN
ajmpe-262	109	28	-	-	PUNCT
ajmpe-262	109	29	specific	specific	ADJ
ajmpe-262	109	30	risk	risk	NOUN
ajmpe-262	109	31	behaviors	behavior	NOUN
ajmpe-262	109	32	not	not	PART
ajmpe-262	109	33	assessed	assess	VERB
ajmpe-262	109	34	in	in	ADP
ajmpe-262	109	35	this	this	DET
ajmpe-262	109	36	study	study	NOUN
ajmpe-262	109	37	.	.	PUNCT
ajmpe-262	110	1	the	the	DET
ajmpe-262	110	2	age	age	NOUN
ajmpe-262	110	3	-	-	PUNCT
ajmpe-262	110	4	specific	specific	ADJ
ajmpe-262	110	5	analysis	analysis	NOUN
ajmpe-262	110	6	revealed	reveal	VERB
ajmpe-262	110	7	that	that	SCONJ
ajmpe-262	110	8	younger	young	ADJ
ajmpe-262	110	9	students	student	NOUN
ajmpe-262	110	10	(	(	PUNCT
ajmpe-262	110	11	18	18	NUM
ajmpe-262	110	12	-	-	SYM
ajmpe-262	110	13	21	21	NUM
ajmpe-262	110	14	years	year	NOUN
ajmpe-262	110	15	)	)	PUNCT
ajmpe-262	110	16	had	have	VERB
ajmpe-262	110	17	a	a	DET
ajmpe-262	110	18	higher	high	ADJ
ajmpe-262	110	19	prevalence	prevalence	NOUN
ajmpe-262	110	20	(	(	PUNCT
ajmpe-262	110	21	12.5	12.5	NUM
ajmpe-262	110	22	%	%	NOUN
ajmpe-262	110	23	)	)	PUNCT
ajmpe-262	110	24	of	of	ADP
ajmpe-262	110	25	hbsag	hbsag	NOUN
ajmpe-262	110	26	compared	compare	VERB
ajmpe-262	110	27	to	to	ADP
ajmpe-262	110	28	older	old	ADJ
ajmpe-262	110	29	students	student	NOUN
ajmpe-262	110	30	(	(	PUNCT
ajmpe-262	110	31	4	4	NUM
ajmpe-262	110	32	%	%	NOUN
ajmpe-262	110	33	in	in	ADP
ajmpe-262	110	34	the	the	DET
ajmpe-262	110	35	22	22	NUM
ajmpe-262	110	36	-	-	SYM
ajmpe-262	110	37	25	25	NUM
ajmpe-262	110	38	age	age	NOUN
ajmpe-262	110	39	group	group	NOUN
ajmpe-262	110	40	and	and	CCONJ
ajmpe-262	110	41	0	0	NUM
ajmpe-262	110	42	%	%	NOUN
ajmpe-262	110	43	in	in	ADP
ajmpe-262	110	44	those	those	DET
ajmpe-262	110	45	>	>	SYM
ajmpe-262	110	46	26	26	NUM
ajmpe-262	110	47	years	year	NOUN
ajmpe-262	110	48	)	)	PUNCT
ajmpe-262	110	49	.	.	PUNCT
ajmpe-262	111	1	this	this	DET
ajmpe-262	111	2	finding	finding	NOUN
ajmpe-262	111	3	aligns	align	VERB
ajmpe-262	111	4	with	with	ADP
ajmpe-262	111	5	other	other	ADJ
ajmpe-262	111	6	studies	study	NOUN
ajmpe-262	111	7	that	that	PRON
ajmpe-262	111	8	have	have	AUX
ajmpe-262	111	9	reported	report	VERB
ajmpe-262	111	10	higher	high	ADJ
ajmpe-262	111	11	hbv	hbv	NOUN
ajmpe-262	111	12	infection	infection	NOUN
ajmpe-262	111	13	rates	rate	NOUN
ajmpe-262	111	14	among	among	ADP
ajmpe-262	111	15	younger	young	ADJ
ajmpe-262	111	16	adults	adult	NOUN
ajmpe-262	111	17	in	in	ADP
ajmpe-262	111	18	nigeria	nigeria	PROPN
ajmpe-262	111	19	(	(	PUNCT
ajmpe-262	111	20	musa	musa	PROPN
ajmpe-262	111	21	et	et	PROPN
ajmpe-262	111	22	al	al	PROPN
ajmpe-262	111	23	.	.	PROPN
ajmpe-262	111	24	,	,	PUNCT
ajmpe-262	111	25	2015	2015	NUM
ajmpe-262	111	26	)	)	PUNCT
ajmpe-262	111	27	.	.	PUNCT
ajmpe-262	112	1	this	this	PRON
ajmpe-262	112	2	could	could	AUX
ajmpe-262	112	3	be	be	AUX
ajmpe-262	112	4	attributed	attribute	VERB
ajmpe-262	112	5	to	to	ADP
ajmpe-262	112	6	lower	low	ADJ
ajmpe-262	112	7	vaccination	vaccination	NOUN
ajmpe-262	112	8	coverage	coverage	NOUN
ajmpe-262	112	9	among	among	ADP
ajmpe-262	112	10	younger	young	ADJ
ajmpe-262	112	11	students	student	NOUN
ajmpe-262	112	12	,	,	PUNCT
ajmpe-262	112	13	as	as	SCONJ
ajmpe-262	112	14	the	the	DET
ajmpe-262	112	15	national	national	ADJ
ajmpe-262	112	16	hbv	hbv	PROPN
ajmpe-262	112	17	vaccination	vaccination	NOUN
ajmpe-262	112	18	program	program	NOUN
ajmpe-262	112	19	in	in	ADP
ajmpe-262	112	20	nigeria	nigeria	PROPN
ajmpe-262	112	21	has	have	AUX
ajmpe-262	112	22	faced	face	VERB
ajmpe-262	112	23	implementation	implementation	NOUN
ajmpe-262	112	24	challenges	challenge	NOUN
ajmpe-262	112	25	,	,	PUNCT
ajmpe-262	112	26	or	or	CCONJ
ajmpe-262	112	27	to	to	ADP
ajmpe-262	112	28	behavioral	behavioral	ADJ
ajmpe-262	112	29	factors	factor	NOUN
ajmpe-262	112	30	such	such	ADJ
ajmpe-262	112	31	as	as	ADP
ajmpe-262	112	32	higher	high	ADJ
ajmpe-262	112	33	engagement	engagement	NOUN
ajmpe-262	112	34	in	in	ADP
ajmpe-262	112	35	risk	risk	NOUN
ajmpe-262	112	36	behaviors	behavior	NOUN
ajmpe-262	112	37	among	among	ADP
ajmpe-262	112	38	younger	young	ADJ
ajmpe-262	112	39	students	student	NOUN
ajmpe-262	112	40	.	.	PUNCT
ajmpe-262	113	1	the	the	DET
ajmpe-262	113	2	departmental	departmental	ADJ
ajmpe-262	113	3	distribution	distribution	NOUN
ajmpe-262	113	4	of	of	ADP
ajmpe-262	113	5	hbsag	hbsag	ADJ
ajmpe-262	113	6	positivity	positivity	NOUN
ajmpe-262	113	7	showed	show	VERB
ajmpe-262	113	8	marked	mark	VERB
ajmpe-262	113	9	variation	variation	NOUN
ajmpe-262	113	10	,	,	PUNCT
ajmpe-262	113	11	with	with	ADP
ajmpe-262	113	12	the	the	DET
ajmpe-262	113	13	environmental	environmental	PROPN
ajmpe-262	113	14	health	health	PROPN
ajmpe-262	113	15	department	department	PROPN
ajmpe-262	113	16	having	have	VERB
ajmpe-262	113	17	the	the	DET
ajmpe-262	113	18	highest	high	ADJ
ajmpe-262	113	19	prevalence	prevalence	NOUN
ajmpe-262	113	20	(	(	PUNCT
ajmpe-262	113	21	27.1	27.1	NUM
ajmpe-262	113	22	%	%	NOUN
ajmpe-262	113	23	)	)	PUNCT
ajmpe-262	113	24	.	.	PUNCT
ajmpe-262	114	1	this	this	DET
ajmpe-262	114	2	striking	striking	ADJ
ajmpe-262	114	3	difference	difference	NOUN
ajmpe-262	114	4	might	might	AUX
ajmpe-262	114	5	be	be	AUX
ajmpe-262	114	6	related	relate	VERB
ajmpe-262	114	7	to	to	ADP
ajmpe-262	114	8	specific	specific	ADJ
ajmpe-262	114	9	exposures	exposure	NOUN
ajmpe-262	114	10	during	during	ADP
ajmpe-262	114	11	practical	practical	ADJ
ajmpe-262	114	12	training	training	NOUN
ajmpe-262	114	13	,	,	PUNCT
ajmpe-262	114	14	such	such	ADJ
ajmpe-262	114	15	as	as	ADP
ajmpe-262	114	16	handling	handle	VERB
ajmpe-262	114	17	waste	waste	NOUN
ajmpe-262	114	18	materials	material	NOUN
ajmpe-262	114	19	or	or	CCONJ
ajmpe-262	114	20	engagement	engagement	NOUN
ajmpe-262	114	21	in	in	ADP
ajmpe-262	114	22	community	community	NOUN
ajmpe-262	114	23	-	-	PUNCT
ajmpe-262	114	24	based	base	VERB
ajmpe-262	114	25	fieldwork	fieldwork	NOUN
ajmpe-262	114	26	where	where	SCONJ
ajmpe-262	114	27	students	student	NOUN
ajmpe-262	114	28	might	might	AUX
ajmpe-262	114	29	be	be	AUX
ajmpe-262	114	30	exposed	expose	VERB
ajmpe-262	114	31	to	to	ADP
ajmpe-262	114	32	contaminated	contaminate	VERB
ajmpe-262	114	33	materials	material	NOUN
ajmpe-262	114	34	.	.	PUNCT
ajmpe-262	115	1	the	the	DET
ajmpe-262	115	2	absence	absence	NOUN
ajmpe-262	115	3	of	of	ADP
ajmpe-262	115	4	positive	positive	ADJ
ajmpe-262	115	5	cases	case	NOUN
ajmpe-262	115	6	in	in	ADP
ajmpe-262	115	7	departments	department	NOUN
ajmpe-262	115	8	such	such	ADJ
ajmpe-262	115	9	as	as	ADP
ajmpe-262	115	10	medical	medical	ADJ
ajmpe-262	115	11	laboratory	laboratory	NOUN
ajmpe-262	115	12	science	science	NOUN
ajmpe-262	115	13	,	,	PUNCT
ajmpe-262	115	14	despite	despite	SCONJ
ajmpe-262	115	15	potential	potential	ADJ
ajmpe-262	115	16	occupational	occupational	ADJ
ajmpe-262	115	17	exposure	exposure	NOUN
ajmpe-262	115	18	to	to	ADP
ajmpe-262	115	19	blood	blood	NOUN
ajmpe-262	115	20	and	and	CCONJ
ajmpe-262	115	21	body	body	NOUN
ajmpe-262	115	22	fluids	fluid	NOUN
ajmpe-262	115	23	,	,	PUNCT
ajmpe-262	115	24	might	might	AUX
ajmpe-262	115	25	suggest	suggest	VERB
ajmpe-262	115	26	better	well	ADJ
ajmpe-262	115	27	awareness	awareness	NOUN
ajmpe-262	115	28	and	and	CCONJ
ajmpe-262	115	29	adherence	adherence	NOUN
ajmpe-262	115	30	to	to	ADP
ajmpe-262	115	31	standard	standard	ADJ
ajmpe-262	115	32	precautions	precaution	NOUN
ajmpe-262	115	33	among	among	ADP
ajmpe-262	115	34	these	these	DET
ajmpe-262	115	35	students	student	NOUN
ajmpe-262	115	36	due	due	ADP
ajmpe-262	115	37	to	to	ADP
ajmpe-262	115	38	their	their	PRON
ajmpe-262	115	39	specialized	specialized	ADJ
ajmpe-262	115	40	training	training	NOUN
ajmpe-262	115	41	.	.	PUNCT
ajmpe-262	116	1	several	several	ADJ
ajmpe-262	116	2	limitations	limitation	NOUN
ajmpe-262	116	3	should	should	AUX
ajmpe-262	116	4	be	be	AUX
ajmpe-262	116	5	considered	consider	VERB
ajmpe-262	116	6	when	when	SCONJ
ajmpe-262	116	7	interpreting	interpret	VERB
ajmpe-262	116	8	the	the	DET
ajmpe-262	116	9	results	result	NOUN
ajmpe-262	116	10	of	of	ADP
ajmpe-262	116	11	this	this	DET
ajmpe-262	116	12	study	study	NOUN
ajmpe-262	116	13	.	.	PUNCT
ajmpe-262	117	1	the	the	DET
ajmpe-262	117	2	relatively	relatively	ADV
ajmpe-262	117	3	small	small	ADJ
ajmpe-262	117	4	sample	sample	NOUN
ajmpe-262	117	5	size	size	NOUN
ajmpe-262	117	6	(	(	PUNCT
ajmpe-262	117	7	n=100	n=100	NUM
ajmpe-262	117	8	)	)	PUNCT
ajmpe-262	117	9	may	may	AUX
ajmpe-262	117	10	not	not	PART
ajmpe-262	117	11	be	be	AUX
ajmpe-262	117	12	fully	fully	ADV
ajmpe-262	117	13	representative	representative	ADJ
ajmpe-262	117	14	of	of	ADP
ajmpe-262	117	15	the	the	DET
ajmpe-262	117	16	entire	entire	ADJ
ajmpe-262	117	17	student	student	NOUN
ajmpe-262	117	18	population	population	NOUN
ajmpe-262	117	19	of	of	ADP
ajmpe-262	117	20	approximately	approximately	ADV
ajmpe-262	117	21	10,000	10,000	NUM
ajmpe-262	117	22	.	.	PUNCT
ajmpe-262	118	1	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-262	118	2	american	american	PROPN
ajmpe-262	118	3	journal	journal	PROPN
ajmpe-262	118	4	of	of	ADP
ajmpe-262	118	5	medical	medical	ADJ
ajmpe-262	118	6	and	and	CCONJ
ajmpe-262	118	7	physical	physical	ADJ
ajmpe-262	118	8	education	education	NOUN
ajmpe-262	118	9	vol.10	vol.10	NOUN
ajmpe-262	118	10	,	,	PUNCT
ajmpe-262	118	11	issue	issue	NOUN
ajmpe-262	118	12	4	4	NUM
ajmpe-262	118	13	;	;	PUNCT
ajmpe-262	118	14	july	july	PROPN
ajmpe-262	118	15	-	-	PUNCT
ajmpe-262	118	16	august	august	PROPN
ajmpe-262	118	17	2025	2025	NUM
ajmpe-262	118	18	;	;	PUNCT
ajmpe-262	118	19	issn	issn	PROPN
ajmpe-262	118	20	:	:	PUNCT
ajmpe-262	118	21	2994	2994	NUM
ajmpe-262	118	22	-	-	SYM
ajmpe-262	118	23	0524	0524	NUM
ajmpe-262	118	24	impact	impact	NOUN
ajmpe-262	118	25	factor	factor	NOUN
ajmpe-262	118	26	:	:	PUNCT
ajmpe-262	118	27	7.06	7.06	NUM
ajmpe-262	118	28	1252	1252	NUM
ajmpe-262	118	29	columbia	columbia	PROPN
ajmpe-262	118	30	rd	rd	PROPN
ajmpe-262	118	31	nw	nw	PROPN
ajmpe-262	118	32	,	,	PUNCT
ajmpe-262	118	33	washington	washington	PROPN
ajmpe-262	118	34	dc	dc	PROPN
ajmpe-262	118	35	,	,	PUNCT
ajmpe-262	118	36	united	united	PROPN
ajmpe-262	118	37	states	states	PROPN
ajmpe-262	118	38	https://topjournals.org/index.php/	https://topjournals.org/index.php/	PROPN
ajmpe-262	118	39	ajmpe	ajmpe	NOUN
ajmpe-262	118	40	;	;	PUNCT
ajmpe-262	118	41	mail	mail	NOUN
ajmpe-262	118	42	:	:	PUNCT
ajmpe-262	118	43	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-262	118	44	5	5	NUM
ajmpe-262	119	1	|	|	ADV
ajmpe-262	119	2	a	a	DET
ajmpe-262	119	3	m	m	NOUN
ajmpe-262	119	4	e	e	NOUN
ajmpe-262	119	5	r	r	NOUN
ajmpe-262	119	6	i	i	NOUN
ajmpe-262	119	7	c	c	VERB
ajmpe-262	119	8	a	a	DET
ajmpe-262	119	9	n	n	NOUN
ajmpe-262	120	1	j	j	NOUN
ajmpe-262	120	2	o	o	X
ajmpe-262	120	3	u	u	NOUN
ajmpe-262	120	4	r	r	NOUN
ajmpe-262	120	5	n	n	NOUN
ajmpe-262	120	6	a	a	DET
ajmpe-262	120	7	l	l	NOUN
ajmpe-262	120	8	o	o	X
ajmpe-262	121	1	f	f	X
ajmpe-262	121	2	m	m	NOUN
ajmpe-262	121	3	e	e	NOUN
ajmpe-262	122	1	d	d	NOUN
ajmpe-262	122	2	i	i	PRON
ajmpe-262	122	3	c	c	VERB
ajmpe-262	122	4	a	a	DET
ajmpe-262	122	5	l	l	NOUN
ajmpe-262	122	6	a	a	X
ajmpe-262	122	7	n	n	NOUN
ajmpe-262	123	1	d	d	NOUN
ajmpe-262	123	2	p	p	NOUN
ajmpe-262	123	3	h	h	NOUN
ajmpe-262	123	4	y	y	NOUN
ajmpe-262	123	5	s	s	VERB
ajmpe-262	124	1	i	i	INTJ
ajmpe-262	124	2	c	c	VERB
ajmpe-262	124	3	a	a	DET
ajmpe-262	124	4	l	l	NOUN
ajmpe-262	124	5	e	e	NOUN
ajmpe-262	124	6	d	d	X
ajmpe-262	124	7	u	u	X
ajmpe-262	124	8	c	c	PROPN
ajmpe-262	125	1	a	a	DET
ajmpe-262	125	2	t	t	NOUN
ajmpe-262	126	1	i	i	PRON
ajmpe-262	126	2	o	o	VERB
ajmpe-262	127	1	n	n	CCONJ
ajmpe-262	127	2	|	|	ADV
ajmpe-262	127	3	https://topjournals.org/index.php/	https://topjournals.org/index.php/	INTJ
ajmpe-262	127	4	ajmpe	ajmpe	NOUN
ajmpe-262	127	5	additionally	additionally	ADV
ajmpe-262	127	6	,	,	PUNCT
ajmpe-262	127	7	the	the	DET
ajmpe-262	127	8	study	study	NOUN
ajmpe-262	127	9	relied	rely	VERB
ajmpe-262	127	10	solely	solely	ADV
ajmpe-262	127	11	on	on	ADP
ajmpe-262	127	12	hbsag	hbsag	ADJ
ajmpe-262	127	13	detection	detection	NOUN
ajmpe-262	127	14	without	without	ADP
ajmpe-262	127	15	assessing	assess	VERB
ajmpe-262	127	16	other	other	ADJ
ajmpe-262	127	17	serological	serological	ADJ
ajmpe-262	127	18	markers	marker	NOUN
ajmpe-262	127	19	of	of	ADP
ajmpe-262	127	20	hbv	hbv	NOUN
ajmpe-262	127	21	infection	infection	NOUN
ajmpe-262	127	22	such	such	ADJ
ajmpe-262	127	23	as	as	ADP
ajmpe-262	127	24	anti	anti	ADJ
ajmpe-262	127	25	-	-	ADJ
ajmpe-262	127	26	hbc	hbc	ADJ
ajmpe-262	127	27	,	,	PUNCT
ajmpe-262	127	28	anti	anti	ADJ
ajmpe-262	127	29	-	-	ADJ
ajmpe-262	127	30	hbs	hbs	ADJ
ajmpe-262	127	31	,	,	PUNCT
ajmpe-262	127	32	or	or	CCONJ
ajmpe-262	127	33	hbeag	hbeag	NOUN
ajmpe-262	127	34	,	,	PUNCT
ajmpe-262	127	35	which	which	PRON
ajmpe-262	127	36	would	would	AUX
ajmpe-262	127	37	have	have	AUX
ajmpe-262	127	38	provided	provide	VERB
ajmpe-262	127	39	a	a	DET
ajmpe-262	127	40	more	more	ADV
ajmpe-262	127	41	comprehensive	comprehensive	ADJ
ajmpe-262	127	42	understanding	understanding	NOUN
ajmpe-262	127	43	of	of	ADP
ajmpe-262	127	44	the	the	DET
ajmpe-262	127	45	infection	infection	NOUN
ajmpe-262	127	46	status	status	NOUN
ajmpe-262	127	47	.	.	PUNCT
ajmpe-262	128	1	furthermore	furthermore	ADV
ajmpe-262	128	2	,	,	PUNCT
ajmpe-262	128	3	the	the	DET
ajmpe-262	128	4	study	study	NOUN
ajmpe-262	128	5	did	do	AUX
ajmpe-262	128	6	not	not	PART
ajmpe-262	128	7	evaluate	evaluate	VERB
ajmpe-262	128	8	risk	risk	NOUN
ajmpe-262	128	9	factors	factor	NOUN
ajmpe-262	128	10	associated	associate	VERB
ajmpe-262	128	11	with	with	ADP
ajmpe-262	128	12	hbv	hbv	NOUN
ajmpe-262	128	13	infection	infection	NOUN
ajmpe-262	128	14	,	,	PUNCT
ajmpe-262	128	15	limiting	limit	VERB
ajmpe-262	128	16	our	our	PRON
ajmpe-262	128	17	ability	ability	NOUN
ajmpe-262	128	18	to	to	PART
ajmpe-262	128	19	explain	explain	VERB
ajmpe-262	128	20	the	the	DET
ajmpe-262	128	21	observed	observed	ADJ
ajmpe-262	128	22	prevalence	prevalence	NOUN
ajmpe-262	128	23	patterns	pattern	NOUN
ajmpe-262	128	24	.	.	PUNCT
ajmpe-262	129	1	despite	despite	SCONJ
ajmpe-262	129	2	these	these	DET
ajmpe-262	129	3	limitations	limitation	NOUN
ajmpe-262	129	4	,	,	PUNCT
ajmpe-262	129	5	our	our	PRON
ajmpe-262	129	6	findings	finding	NOUN
ajmpe-262	129	7	highlight	highlight	VERB
ajmpe-262	129	8	a	a	DET
ajmpe-262	129	9	significant	significant	ADJ
ajmpe-262	129	10	prevalence	prevalence	NOUN
ajmpe-262	129	11	of	of	ADP
ajmpe-262	129	12	hbsag	hbsag	NOUN
ajmpe-262	129	13	among	among	ADP
ajmpe-262	129	14	college	college	NOUN
ajmpe-262	129	15	students	student	NOUN
ajmpe-262	129	16	,	,	PUNCT
ajmpe-262	129	17	particularly	particularly	ADV
ajmpe-262	129	18	among	among	ADP
ajmpe-262	129	19	younger	young	ADJ
ajmpe-262	129	20	females	female	NOUN
ajmpe-262	129	21	and	and	CCONJ
ajmpe-262	129	22	students	student	NOUN
ajmpe-262	129	23	in	in	ADP
ajmpe-262	129	24	specific	specific	ADJ
ajmpe-262	129	25	departments	department	NOUN
ajmpe-262	129	26	,	,	PUNCT
ajmpe-262	129	27	warranting	warrant	VERB
ajmpe-262	129	28	targeted	target	VERB
ajmpe-262	129	29	interventions	intervention	NOUN
ajmpe-262	129	30	.	.	PUNCT
ajmpe-262	130	1	conclusion	conclusion	NOUN
ajmpe-262	130	2	this	this	DET
ajmpe-262	130	3	study	study	NOUN
ajmpe-262	130	4	revealed	reveal	VERB
ajmpe-262	130	5	a	a	DET
ajmpe-262	130	6	7	7	NUM
ajmpe-262	130	7	%	%	NOUN
ajmpe-262	130	8	prevalence	prevalence	NOUN
ajmpe-262	130	9	of	of	ADP
ajmpe-262	130	10	hbsag	hbsag	NOUN
ajmpe-262	130	11	among	among	ADP
ajmpe-262	130	12	students	student	NOUN
ajmpe-262	130	13	of	of	ADP
ajmpe-262	130	14	kwara	kwara	PROPN
ajmpe-262	130	15	state	state	PROPN
ajmpe-262	130	16	college	college	PROPN
ajmpe-262	130	17	of	of	ADP
ajmpe-262	130	18	health	health	PROPN
ajmpe-262	130	19	technology	technology	NOUN
ajmpe-262	130	20	,	,	PUNCT
ajmpe-262	130	21	offa	offa	NOUN
ajmpe-262	130	22	,	,	PUNCT
ajmpe-262	130	23	nigeria	nigeria	PRON
ajmpe-262	130	24	,	,	PUNCT
ajmpe-262	130	25	with	with	ADP
ajmpe-262	130	26	higher	high	ADJ
ajmpe-262	130	27	rates	rate	NOUN
ajmpe-262	130	28	observed	observe	VERB
ajmpe-262	130	29	among	among	ADP
ajmpe-262	130	30	females	female	NOUN
ajmpe-262	130	31	,	,	PUNCT
ajmpe-262	130	32	younger	young	ADJ
ajmpe-262	130	33	students	student	NOUN
ajmpe-262	130	34	(	(	PUNCT
ajmpe-262	130	35	18	18	NUM
ajmpe-262	130	36	-	-	SYM
ajmpe-262	130	37	21	21	NUM
ajmpe-262	130	38	years	year	NOUN
ajmpe-262	130	39	)	)	PUNCT
ajmpe-262	130	40	,	,	PUNCT
ajmpe-262	130	41	and	and	CCONJ
ajmpe-262	130	42	students	student	NOUN
ajmpe-262	130	43	in	in	ADP
ajmpe-262	130	44	the	the	DET
ajmpe-262	130	45	environmental	environmental	PROPN
ajmpe-262	130	46	health	health	PROPN
ajmpe-262	130	47	department	department	PROPN
ajmpe-262	130	48	.	.	PUNCT
ajmpe-262	131	1	these	these	DET
ajmpe-262	131	2	findings	finding	NOUN
ajmpe-262	131	3	underscore	underscore	VERB
ajmpe-262	131	4	the	the	DET
ajmpe-262	131	5	need	need	NOUN
ajmpe-262	131	6	for	for	ADP
ajmpe-262	131	7	comprehensive	comprehensive	ADJ
ajmpe-262	131	8	prevention	prevention	NOUN
ajmpe-262	131	9	strategies	strategy	NOUN
ajmpe-262	131	10	,	,	PUNCT
ajmpe-262	131	11	including	include	VERB
ajmpe-262	131	12	screening	screening	NOUN
ajmpe-262	131	13	,	,	PUNCT
ajmpe-262	131	14	vaccination	vaccination	NOUN
ajmpe-262	131	15	,	,	PUNCT
ajmpe-262	131	16	and	and	CCONJ
ajmpe-262	131	17	education	education	NOUN
ajmpe-262	131	18	programs	program	NOUN
ajmpe-262	131	19	specifically	specifically	ADV
ajmpe-262	131	20	targeting	target	VERB
ajmpe-262	131	21	high	high	ADJ
ajmpe-262	131	22	-	-	PUNCT
ajmpe-262	131	23	risk	risk	NOUN
ajmpe-262	131	24	groups	group	NOUN
ajmpe-262	131	25	within	within	ADP
ajmpe-262	131	26	the	the	DET
ajmpe-262	131	27	college	college	NOUN
ajmpe-262	131	28	population	population	NOUN
ajmpe-262	131	29	.	.	PUNCT
ajmpe-262	132	1	recommendations	recommendation	NOUN
ajmpe-262	132	2	based	base	VERB
ajmpe-262	132	3	on	on	ADP
ajmpe-262	132	4	the	the	DET
ajmpe-262	132	5	findings	finding	NOUN
ajmpe-262	132	6	of	of	ADP
ajmpe-262	132	7	this	this	DET
ajmpe-262	132	8	study	study	NOUN
ajmpe-262	132	9	,	,	PUNCT
ajmpe-262	132	10	we	we	PRON
ajmpe-262	132	11	recommend	recommend	VERB
ajmpe-262	132	12	:	:	PUNCT
ajmpe-262	132	13	1	1	X
ajmpe-262	132	14	.	.	X
ajmpe-262	132	15	implementation	implementation	NOUN
ajmpe-262	132	16	of	of	ADP
ajmpe-262	132	17	routine	routine	ADJ
ajmpe-262	132	18	hbv	hbv	NOUN
ajmpe-262	132	19	screening	screen	VERB
ajmpe-262	132	20	for	for	SCONJ
ajmpe-262	132	21	all	all	DET
ajmpe-262	132	22	new	new	ADJ
ajmpe-262	132	23	and	and	CCONJ
ajmpe-262	132	24	continuing	continue	VERB
ajmpe-262	132	25	students	student	NOUN
ajmpe-262	132	26	in	in	ADP
ajmpe-262	132	27	tertiary	tertiary	ADJ
ajmpe-262	132	28	institutions	institution	NOUN
ajmpe-262	132	29	in	in	ADP
ajmpe-262	132	30	nigeria	nigeria	PROPN
ajmpe-262	132	31	to	to	PART
ajmpe-262	132	32	identify	identify	VERB
ajmpe-262	132	33	infected	infect	VERB
ajmpe-262	132	34	individuals	individual	NOUN
ajmpe-262	132	35	for	for	ADP
ajmpe-262	132	36	appropriate	appropriate	ADJ
ajmpe-262	132	37	management	management	NOUN
ajmpe-262	132	38	and	and	CCONJ
ajmpe-262	132	39	to	to	PART
ajmpe-262	132	40	prevent	prevent	VERB
ajmpe-262	132	41	transmission	transmission	NOUN
ajmpe-262	132	42	.	.	PUNCT
ajmpe-262	133	1	2	2	X
ajmpe-262	133	2	.	.	X
ajmpe-262	133	3	strengthening	strengthening	NOUN
ajmpe-262	133	4	of	of	ADP
ajmpe-262	133	5	hbv	hbv	NOUN
ajmpe-262	133	6	vaccination	vaccination	NOUN
ajmpe-262	133	7	programs	program	NOUN
ajmpe-262	133	8	within	within	ADP
ajmpe-262	133	9	educational	educational	ADJ
ajmpe-262	133	10	institutions	institution	NOUN
ajmpe-262	133	11	,	,	PUNCT
ajmpe-262	133	12	with	with	ADP
ajmpe-262	133	13	particular	particular	ADJ
ajmpe-262	133	14	focus	focus	NOUN
ajmpe-262	133	15	on	on	ADP
ajmpe-262	133	16	departments	department	NOUN
ajmpe-262	133	17	with	with	ADP
ajmpe-262	133	18	higher	high	ADJ
ajmpe-262	133	19	prevalence	prevalence	NOUN
ajmpe-262	133	20	rates	rate	NOUN
ajmpe-262	133	21	.	.	PUNCT
ajmpe-262	134	1	3	3	X
ajmpe-262	134	2	.	.	X
ajmpe-262	134	3	development	development	NOUN
ajmpe-262	134	4	of	of	ADP
ajmpe-262	134	5	educational	educational	ADJ
ajmpe-262	134	6	campaigns	campaign	NOUN
ajmpe-262	134	7	to	to	PART
ajmpe-262	134	8	increase	increase	VERB
ajmpe-262	134	9	awareness	awareness	NOUN
ajmpe-262	134	10	about	about	ADP
ajmpe-262	134	11	hbv	hbv	NOUN
ajmpe-262	134	12	transmission	transmission	NOUN
ajmpe-262	134	13	,	,	PUNCT
ajmpe-262	134	14	prevention	prevention	NOUN
ajmpe-262	134	15	,	,	PUNCT
ajmpe-262	134	16	and	and	CCONJ
ajmpe-262	134	17	the	the	DET
ajmpe-262	134	18	importance	importance	NOUN
ajmpe-262	134	19	of	of	ADP
ajmpe-262	134	20	vaccination	vaccination	NOUN
ajmpe-262	134	21	,	,	PUNCT
ajmpe-262	134	22	especially	especially	ADV
ajmpe-262	134	23	targeting	target	VERB
ajmpe-262	134	24	younger	young	ADJ
ajmpe-262	134	25	students	student	NOUN
ajmpe-262	134	26	and	and	CCONJ
ajmpe-262	134	27	departments	department	NOUN
ajmpe-262	134	28	with	with	ADP
ajmpe-262	134	29	higher	high	ADJ
ajmpe-262	134	30	prevalence	prevalence	NOUN
ajmpe-262	134	31	.	.	PUNCT
ajmpe-262	135	1	4	4	X
ajmpe-262	135	2	.	.	X
ajmpe-262	135	3	enhancement	enhancement	NOUN
ajmpe-262	135	4	of	of	ADP
ajmpe-262	135	5	infection	infection	NOUN
ajmpe-262	135	6	control	control	NOUN
ajmpe-262	135	7	practices	practice	NOUN
ajmpe-262	135	8	during	during	ADP
ajmpe-262	135	9	practical	practical	ADJ
ajmpe-262	135	10	training	training	NOUN
ajmpe-262	135	11	sessions	session	NOUN
ajmpe-262	135	12	,	,	PUNCT
ajmpe-262	135	13	particularly	particularly	ADV
ajmpe-262	135	14	for	for	ADP
ajmpe-262	135	15	students	student	NOUN
ajmpe-262	135	16	in	in	ADP
ajmpe-262	135	17	environmental	environmental	ADJ
ajmpe-262	135	18	health	health	NOUN
ajmpe-262	135	19	and	and	CCONJ
ajmpe-262	135	20	other	other	ADJ
ajmpe-262	135	21	departments	department	NOUN
ajmpe-262	135	22	with	with	ADP
ajmpe-262	135	23	potential	potential	ADJ
ajmpe-262	135	24	exposure	exposure	NOUN
ajmpe-262	135	25	to	to	ADP
ajmpe-262	135	26	blood	blood	NOUN
ajmpe-262	135	27	and	and	CCONJ
ajmpe-262	135	28	body	body	NOUN
ajmpe-262	135	29	fluids	fluid	NOUN
ajmpe-262	135	30	.	.	PUNCT
ajmpe-262	136	1	5	5	X
ajmpe-262	136	2	.	.	X
ajmpe-262	136	3	conducting	conduct	VERB
ajmpe-262	136	4	larger	large	ADJ
ajmpe-262	136	5	,	,	PUNCT
ajmpe-262	136	6	multi	multi	ADJ
ajmpe-262	136	7	-	-	ADJ
ajmpe-262	136	8	center	center	ADJ
ajmpe-262	136	9	studies	study	NOUN
ajmpe-262	136	10	with	with	ADP
ajmpe-262	136	11	more	more	ADV
ajmpe-262	136	12	comprehensive	comprehensive	ADJ
ajmpe-262	136	13	serological	serological	ADJ
ajmpe-262	136	14	testing	testing	NOUN
ajmpe-262	136	15	and	and	CCONJ
ajmpe-262	136	16	risk	risk	NOUN
ajmpe-262	136	17	factor	factor	NOUN
ajmpe-262	136	18	assessment	assessment	NOUN
ajmpe-262	136	19	to	to	PART
ajmpe-262	136	20	better	well	ADV
ajmpe-262	136	21	understand	understand	VERB
ajmpe-262	136	22	the	the	DET
ajmpe-262	136	23	epidemiology	epidemiology	NOUN
ajmpe-262	136	24	of	of	ADP
ajmpe-262	136	25	hbv	hbv	NOUN
ajmpe-262	136	26	infection	infection	NOUN
ajmpe-262	136	27	among	among	ADP
ajmpe-262	136	28	nigerian	nigerian	ADJ
ajmpe-262	136	29	college	college	NOUN
ajmpe-262	136	30	students	student	NOUN
ajmpe-262	136	31	.	.	PUNCT
ajmpe-262	137	1	acknowledgments	acknowledgment	NOUN
ajmpe-262	137	2	the	the	DET
ajmpe-262	137	3	authors	author	NOUN
ajmpe-262	137	4	thank	thank	VERB
ajmpe-262	137	5	the	the	DET
ajmpe-262	137	6	management	management	NOUN
ajmpe-262	137	7	and	and	CCONJ
ajmpe-262	137	8	students	student	NOUN
ajmpe-262	137	9	of	of	ADP
ajmpe-262	137	10	kwara	kwara	PROPN
ajmpe-262	137	11	state	state	PROPN
ajmpe-262	137	12	college	college	PROPN
ajmpe-262	137	13	of	of	ADP
ajmpe-262	137	14	health	health	PROPN
ajmpe-262	137	15	technology	technology	NOUN
ajmpe-262	137	16	,	,	PUNCT
ajmpe-262	137	17	offa	offa	NOUN
ajmpe-262	137	18	,	,	PUNCT
ajmpe-262	137	19	for	for	ADP
ajmpe-262	137	20	their	their	PRON
ajmpe-262	137	21	cooperation	cooperation	NOUN
ajmpe-262	137	22	and	and	CCONJ
ajmpe-262	137	23	participation	participation	NOUN
ajmpe-262	137	24	in	in	ADP
ajmpe-262	137	25	this	this	DET
ajmpe-262	137	26	study	study	NOUN
ajmpe-262	137	27	.	.	PUNCT
ajmpe-262	138	1	conflicts	conflict	NOUN
ajmpe-262	138	2	of	of	ADP
ajmpe-262	138	3	interest	interest	NOUN
ajmpe-262	138	4	the	the	DET
ajmpe-262	138	5	authors	author	NOUN
ajmpe-262	138	6	declare	declare	VERB
ajmpe-262	138	7	no	no	DET
ajmpe-262	138	8	conflicts	conflict	NOUN
ajmpe-262	138	9	of	of	ADP
ajmpe-262	138	10	interest	interest	NOUN
ajmpe-262	138	11	.	.	PUNCT
ajmpe-262	139	1	references	reference	NOUN
ajmpe-262	139	2	eke	eke	ADJ
ajmpe-262	139	3	,	,	PUNCT
ajmpe-262	139	4	a.	a.	PROPN
ajmpe-262	139	5	c.	c.	PROPN
ajmpe-262	139	6	,	,	PUNCT
ajmpe-262	139	7	eke	eke	ADJ
ajmpe-262	139	8	,	,	PUNCT
ajmpe-262	139	9	u.	u.	PROPN
ajmpe-262	139	10	a.	a.	PROPN
ajmpe-262	139	11	,	,	PUNCT
ajmpe-262	139	12	okafor	okafor	PROPN
ajmpe-262	139	13	,	,	PUNCT
ajmpe-262	139	14	c.	c.	PROPN
ajmpe-262	139	15	i.	i.	PROPN
ajmpe-262	139	16	,	,	PUNCT
ajmpe-262	139	17	ezebialu	ezebialu	PROPN
ajmpe-262	139	18	,	,	PUNCT
ajmpe-262	139	19	i.	i.	PROPN
ajmpe-262	139	20	u.	u.	PROPN
ajmpe-262	139	21	,	,	PUNCT
ajmpe-262	139	22	&	&	CCONJ
ajmpe-262	139	23	ogbuagu	ogbuagu	PROPN
ajmpe-262	139	24	,	,	PUNCT
ajmpe-262	139	25	c.	c.	PROPN
ajmpe-262	139	26	(	(	PUNCT
ajmpe-262	139	27	2011	2011	NUM
ajmpe-262	139	28	)	)	PUNCT
ajmpe-262	139	29	.	.	PUNCT
ajmpe-262	140	1	prevalence	prevalence	NOUN
ajmpe-262	140	2	,	,	PUNCT
ajmpe-262	140	3	correlates	correlate	VERB
ajmpe-262	140	4	and	and	CCONJ
ajmpe-262	140	5	pattern	pattern	NOUN
ajmpe-262	140	6	of	of	ADP
ajmpe-262	140	7	hepatitis	hepatitis	PROPN
ajmpe-262	140	8	b	b	PROPN
ajmpe-262	140	9	surface	surface	NOUN
ajmpe-262	140	10	antigen	antigen	ADV
ajmpe-262	140	11	in	in	ADP
ajmpe-262	140	12	a	a	DET
ajmpe-262	140	13	low	low	ADJ
ajmpe-262	140	14	resource	resource	NOUN
ajmpe-262	140	15	setting	setting	NOUN
ajmpe-262	140	16	.	.	PUNCT
ajmpe-262	141	1	virology	virology	NOUN
ajmpe-262	141	2	journal	journal	NOUN
ajmpe-262	141	3	,	,	PUNCT
ajmpe-262	141	4	8	8	NUM
ajmpe-262	141	5	,	,	PUNCT
ajmpe-262	141	6	12	12	NUM
ajmpe-262	141	7	.	.	PUNCT
ajmpe-262	142	1	https://doi.org/10.1186/1743-422x-8-12	https://doi.org/10.1186/1743-422x-8-12	NOUN
ajmpe-262	142	2	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-262	142	3	https://doi.org/10.1186/1743-422x-8-12	https://doi.org/10.1186/1743-422x-8-12	NOUN
ajmpe-262	142	4	american	american	PROPN
ajmpe-262	142	5	journal	journal	PROPN
ajmpe-262	142	6	of	of	ADP
ajmpe-262	142	7	medical	medical	ADJ
ajmpe-262	142	8	and	and	CCONJ
ajmpe-262	142	9	physical	physical	ADJ
ajmpe-262	142	10	education	education	NOUN
ajmpe-262	142	11	vol.10	vol.10	NOUN
ajmpe-262	142	12	,	,	PUNCT
ajmpe-262	142	13	issue	issue	NOUN
ajmpe-262	142	14	4	4	NUM
ajmpe-262	142	15	;	;	PUNCT
ajmpe-262	142	16	july	july	PROPN
ajmpe-262	142	17	-	-	PUNCT
ajmpe-262	142	18	august	august	PROPN
ajmpe-262	142	19	2025	2025	NUM
ajmpe-262	142	20	;	;	PUNCT
ajmpe-262	142	21	issn	issn	PROPN
ajmpe-262	142	22	:	:	PUNCT
ajmpe-262	142	23	2994	2994	NUM
ajmpe-262	142	24	-	-	SYM
ajmpe-262	142	25	0524	0524	NUM
ajmpe-262	142	26	impact	impact	NOUN
ajmpe-262	142	27	factor	factor	NOUN
ajmpe-262	142	28	:	:	PUNCT
ajmpe-262	142	29	7.06	7.06	NUM
ajmpe-262	142	30	1252	1252	NUM
ajmpe-262	142	31	columbia	columbia	PROPN
ajmpe-262	142	32	rd	rd	PROPN
ajmpe-262	142	33	nw	nw	PROPN
ajmpe-262	142	34	,	,	PUNCT
ajmpe-262	142	35	washington	washington	PROPN
ajmpe-262	142	36	dc	dc	PROPN
ajmpe-262	142	37	,	,	PUNCT
ajmpe-262	142	38	united	united	PROPN
ajmpe-262	142	39	states	states	PROPN
ajmpe-262	142	40	https://topjournals.org/index.php/	https://topjournals.org/index.php/	PROPN
ajmpe-262	142	41	ajmpe	ajmpe	NOUN
ajmpe-262	142	42	;	;	PUNCT
ajmpe-262	142	43	mail	mail	NOUN
ajmpe-262	142	44	:	:	PUNCT
ajmpe-262	142	45	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-262	143	1	6	6	NUM
ajmpe-262	144	1	|	|	ADV
ajmpe-262	144	2	a	a	DET
ajmpe-262	144	3	m	m	NOUN
ajmpe-262	144	4	e	e	NOUN
ajmpe-262	144	5	r	r	NOUN
ajmpe-262	144	6	i	i	NOUN
ajmpe-262	144	7	c	c	VERB
ajmpe-262	144	8	a	a	DET
ajmpe-262	144	9	n	n	NOUN
ajmpe-262	145	1	j	j	NOUN
ajmpe-262	145	2	o	o	X
ajmpe-262	145	3	u	u	NOUN
ajmpe-262	145	4	r	r	NOUN
ajmpe-262	145	5	n	n	NOUN
ajmpe-262	145	6	a	a	DET
ajmpe-262	145	7	l	l	NOUN
ajmpe-262	145	8	o	o	X
ajmpe-262	146	1	f	f	X
ajmpe-262	146	2	m	m	NOUN
ajmpe-262	146	3	e	e	NOUN
ajmpe-262	147	1	d	d	NOUN
ajmpe-262	147	2	i	i	PRON
ajmpe-262	147	3	c	c	VERB
ajmpe-262	147	4	a	a	DET
ajmpe-262	147	5	l	l	NOUN
ajmpe-262	147	6	a	a	X
ajmpe-262	147	7	n	n	NOUN
ajmpe-262	148	1	d	d	NOUN
ajmpe-262	148	2	p	p	NOUN
ajmpe-262	148	3	h	h	NOUN
ajmpe-262	148	4	y	y	NOUN
ajmpe-262	148	5	s	s	VERB
ajmpe-262	149	1	i	i	INTJ
ajmpe-262	149	2	c	c	VERB
ajmpe-262	149	3	a	a	DET
ajmpe-262	149	4	l	l	NOUN
ajmpe-262	149	5	e	e	NOUN
ajmpe-262	149	6	d	d	X
ajmpe-262	149	7	u	u	X
ajmpe-262	149	8	c	c	PROPN
ajmpe-262	150	1	a	a	DET
ajmpe-262	150	2	t	t	NOUN
ajmpe-262	151	1	i	i	PRON
ajmpe-262	151	2	o	o	VERB
ajmpe-262	152	1	n	n	CCONJ
ajmpe-262	152	2	|	|	ADV
ajmpe-262	152	3	https://topjournals.org/index.php/	https://topjournals.org/index.php/	INTJ
ajmpe-262	152	4	ajmpe	ajmpe	PROPN
ajmpe-262	152	5	eni	eni	PROPN
ajmpe-262	152	6	,	,	PUNCT
ajmpe-262	152	7	a.	a.	NOUN
ajmpe-262	152	8	o.	o.	PROPN
ajmpe-262	152	9	,	,	PUNCT
ajmpe-262	152	10	soluade	soluade	PROPN
ajmpe-262	152	11	,	,	PUNCT
ajmpe-262	152	12	m.	m.	NOUN
ajmpe-262	152	13	g.	g.	PROPN
ajmpe-262	152	14	,	,	PUNCT
ajmpe-262	152	15	oshamika	oshamika	INTJ
ajmpe-262	152	16	,	,	PUNCT
ajmpe-262	152	17	o.	o.	PROPN
ajmpe-262	152	18	o.	o.	PROPN
ajmpe-262	152	19	,	,	PUNCT
ajmpe-262	152	20	efekemo	efekemo	PROPN
ajmpe-262	152	21	,	,	PUNCT
ajmpe-262	152	22	o.	o.	PROPN
ajmpe-262	152	23	p.	p.	PROPN
ajmpe-262	152	24	,	,	PUNCT
ajmpe-262	152	25	igwe	igwe	PROPN
ajmpe-262	152	26	,	,	PUNCT
ajmpe-262	152	27	t.	t.	PROPN
ajmpe-262	152	28	t.	t.	PROPN
ajmpe-262	152	29	,	,	PUNCT
ajmpe-262	152	30	&	&	CCONJ
ajmpe-262	152	31	onile	onile	NOUN
ajmpe-262	152	32	,	,	PUNCT
ajmpe-262	153	1	o.	o.	PROPN
ajmpe-262	153	2	s.	s.	PROPN
ajmpe-262	153	3	(	(	PUNCT
ajmpe-262	153	4	2018	2018	NUM
ajmpe-262	153	5	)	)	PUNCT
ajmpe-262	153	6	.	.	PUNCT
ajmpe-262	154	1	seroprevalence	seroprevalence	NOUN
ajmpe-262	154	2	of	of	ADP
ajmpe-262	154	3	hepatitis	hepatitis	PROPN
ajmpe-262	154	4	b	b	PROPN
ajmpe-262	154	5	virus	virus	NOUN
ajmpe-262	154	6	and	and	CCONJ
ajmpe-262	154	7	hiv	hiv	PROPN
ajmpe-262	154	8	among	among	ADP
ajmpe-262	154	9	healthy	healthy	ADJ
ajmpe-262	154	10	young	young	ADJ
ajmpe-262	154	11	adults	adult	NOUN
ajmpe-262	154	12	in	in	ADP
ajmpe-262	154	13	south	south	NOUN
ajmpe-262	154	14	-	-	PUNCT
ajmpe-262	154	15	west	west	PROPN
ajmpe-262	154	16	nigeria	nigeria	PROPN
ajmpe-262	154	17	.	.	PUNCT
ajmpe-262	155	1	the	the	DET
ajmpe-262	155	2	pan	pan	PROPN
ajmpe-262	155	3	african	african	PROPN
ajmpe-262	155	4	medical	medical	ADJ
ajmpe-262	155	5	journal	journal	NOUN
ajmpe-262	155	6	,	,	PUNCT
ajmpe-262	155	7	30	30	NUM
ajmpe-262	155	8	,	,	PUNCT
ajmpe-262	155	9	69	69	NUM
ajmpe-262	155	10	.	.	PUNCT
ajmpe-262	156	1	https://doi.org/10.11604/pamj.2018.30.69.14579	https://doi.org/10.11604/pamj.2018.30.69.14579	PROPN
ajmpe-262	156	2	lemoine	lemoine	PROPN
ajmpe-262	156	3	,	,	PUNCT
ajmpe-262	156	4	m.	m.	NOUN
ajmpe-262	156	5	,	,	PUNCT
ajmpe-262	156	6	nayagam	nayagam	NOUN
ajmpe-262	156	7	,	,	PUNCT
ajmpe-262	156	8	s.	s.	PROPN
ajmpe-262	156	9	,	,	PUNCT
ajmpe-262	156	10	&	&	CCONJ
ajmpe-262	156	11	thursz	thursz	NOUN
ajmpe-262	156	12	,	,	PUNCT
ajmpe-262	156	13	m.	m.	NOUN
ajmpe-262	156	14	(	(	PUNCT
ajmpe-262	156	15	2013	2013	NUM
ajmpe-262	156	16	)	)	PUNCT
ajmpe-262	156	17	.	.	PUNCT
ajmpe-262	157	1	viral	viral	ADJ
ajmpe-262	157	2	hepatitis	hepatitis	NOUN
ajmpe-262	157	3	in	in	ADP
ajmpe-262	157	4	resource	resource	NOUN
ajmpe-262	157	5	-	-	PUNCT
ajmpe-262	157	6	limited	limit	VERB
ajmpe-262	157	7	countries	country	NOUN
ajmpe-262	157	8	and	and	CCONJ
ajmpe-262	157	9	access	access	NOUN
ajmpe-262	157	10	to	to	ADP
ajmpe-262	157	11	antiviral	antiviral	ADJ
ajmpe-262	157	12	therapies	therapy	NOUN
ajmpe-262	157	13	:	:	PUNCT
ajmpe-262	157	14	current	current	ADJ
ajmpe-262	157	15	and	and	CCONJ
ajmpe-262	157	16	future	future	ADJ
ajmpe-262	157	17	challenges	challenge	NOUN
ajmpe-262	157	18	.	.	PUNCT
ajmpe-262	158	1	future	future	ADJ
ajmpe-262	158	2	virology	virology	NOUN
ajmpe-262	158	3	,	,	PUNCT
ajmpe-262	158	4	8(4	8(4	NUM
ajmpe-262	158	5	)	)	PUNCT
ajmpe-262	158	6	,	,	PUNCT
ajmpe-262	158	7	371	371	NUM
ajmpe-262	158	8	-	-	SYM
ajmpe-262	158	9	380	380	NUM
ajmpe-262	158	10	.	.	PUNCT
ajmpe-262	159	1	https://doi.org/10.2217/fvl.13.11	https://doi.org/10.2217/fvl.13.11	PROPN
ajmpe-262	159	2	liaw	liaw	PROPN
ajmpe-262	159	3	,	,	PUNCT
ajmpe-262	159	4	y.	y.	PROPN
ajmpe-262	159	5	f.	f.	PROPN
ajmpe-262	159	6	,	,	PUNCT
ajmpe-262	159	7	&	&	CCONJ
ajmpe-262	159	8	chu	chu	PROPN
ajmpe-262	159	9	,	,	PUNCT
ajmpe-262	159	10	c.	c.	PROPN
ajmpe-262	159	11	m.	m.	NOUN
ajmpe-262	159	12	(	(	PUNCT
ajmpe-262	159	13	2009	2009	NUM
ajmpe-262	159	14	)	)	PUNCT
ajmpe-262	159	15	.	.	PUNCT
ajmpe-262	160	1	hepatitis	hepatitis	PROPN
ajmpe-262	160	2	b	b	PROPN
ajmpe-262	160	3	virus	virus	NOUN
ajmpe-262	160	4	infection	infection	NOUN
ajmpe-262	160	5	.	.	PUNCT
ajmpe-262	161	1	the	the	DET
ajmpe-262	161	2	lancet	lancet	NOUN
ajmpe-262	161	3	,	,	PUNCT
ajmpe-262	161	4	373(9663	373(9663	NUM
ajmpe-262	161	5	)	)	PUNCT
ajmpe-262	161	6	,	,	PUNCT
ajmpe-262	161	7	582	582	NUM
ajmpe-262	161	8	-	-	SYM
ajmpe-262	161	9	592	592	NUM
ajmpe-262	161	10	.	.	PUNCT
ajmpe-262	162	1	https://doi.org/10.1016/s0140-6736(09)60207-5	https://doi.org/10.1016/s0140-6736(09)60207-5	PROPN
ajmpe-262	162	2	musa	musa	PROPN
ajmpe-262	162	3	,	,	PUNCT
ajmpe-262	162	4	b.	b.	PROPN
ajmpe-262	162	5	m.	m.	PROPN
ajmpe-262	162	6	,	,	PUNCT
ajmpe-262	162	7	bussell	bussell	VERB
ajmpe-262	162	8	,	,	PUNCT
ajmpe-262	162	9	s.	s.	PROPN
ajmpe-262	162	10	,	,	PUNCT
ajmpe-262	162	11	borodo	borodo	NOUN
ajmpe-262	162	12	,	,	PUNCT
ajmpe-262	162	13	m.	m.	NOUN
ajmpe-262	162	14	m.	m.	NOUN
ajmpe-262	162	15	,	,	PUNCT
ajmpe-262	162	16	samaila	samaila	PROPN
ajmpe-262	162	17	,	,	PUNCT
ajmpe-262	162	18	a.	a.	NOUN
ajmpe-262	162	19	a.	a.	PROPN
ajmpe-262	162	20	,	,	PUNCT
ajmpe-262	162	21	&	&	CCONJ
ajmpe-262	162	22	femi	femi	PROPN
ajmpe-262	162	23	,	,	PUNCT
ajmpe-262	162	24	o.	o.	PROPN
ajmpe-262	162	25	l.	l.	PROPN
ajmpe-262	162	26	(	(	PUNCT
ajmpe-262	162	27	2015	2015	NUM
ajmpe-262	162	28	)	)	PUNCT
ajmpe-262	162	29	.	.	PUNCT
ajmpe-262	163	1	prevalence	prevalence	NOUN
ajmpe-262	163	2	of	of	ADP
ajmpe-262	163	3	hepatitis	hepatitis	PROPN
ajmpe-262	163	4	b	b	PROPN
ajmpe-262	163	5	virus	virus	NOUN
ajmpe-262	163	6	infection	infection	NOUN
ajmpe-262	163	7	in	in	ADP
ajmpe-262	163	8	nigeria	nigeria	PROPN
ajmpe-262	163	9	,	,	PUNCT
ajmpe-262	163	10	2000	2000	NUM
ajmpe-262	163	11	-	-	SYM
ajmpe-262	163	12	2013	2013	NUM
ajmpe-262	163	13	:	:	PUNCT
ajmpe-262	163	14	a	a	DET
ajmpe-262	163	15	systematic	systematic	ADJ
ajmpe-262	163	16	review	review	NOUN
ajmpe-262	163	17	and	and	CCONJ
ajmpe-262	163	18	meta	meta	ADJ
ajmpe-262	163	19	-	-	PUNCT
ajmpe-262	163	20	analysis	analysis	NOUN
ajmpe-262	163	21	.	.	PUNCT
ajmpe-262	164	1	nigerian	nigerian	ADJ
ajmpe-262	164	2	journal	journal	PROPN
ajmpe-262	164	3	of	of	ADP
ajmpe-262	164	4	clinical	clinical	ADJ
ajmpe-262	164	5	practice	practice	NOUN
ajmpe-262	164	6	,	,	PUNCT
ajmpe-262	164	7	18(2	18(2	NUM
ajmpe-262	164	8	)	)	PUNCT
ajmpe-262	164	9	,	,	PUNCT
ajmpe-262	164	10	163	163	NUM
ajmpe-262	164	11	-	-	SYM
ajmpe-262	164	12	172	172	NUM
ajmpe-262	164	13	.	.	PUNCT
ajmpe-262	165	1	https://doi.org/10.4103/1119-3077.151035	https://doi.org/10.4103/1119-3077.151035	PROPN
ajmpe-262	165	2	ndako	ndako	PROPN
ajmpe-262	165	3	,	,	PUNCT
ajmpe-262	165	4	j.	j.	PROPN
ajmpe-262	165	5	a.	a.	PROPN
ajmpe-262	165	6	,	,	PUNCT
ajmpe-262	165	7	nwankiti	nwankiti	PROPN
ajmpe-262	165	8	,	,	PUNCT
ajmpe-262	165	9	o.	o.	PROPN
ajmpe-262	165	10	o.	o.	PROPN
ajmpe-262	165	11	,	,	PUNCT
ajmpe-262	165	12	echeonwu	echeonwu	NOUN
ajmpe-262	165	13	,	,	PUNCT
ajmpe-262	165	14	g.	g.	PROPN
ajmpe-262	165	15	o.	o.	PROPN
ajmpe-262	165	16	,	,	PUNCT
ajmpe-262	165	17	junaid	junaid	PROPN
ajmpe-262	165	18	,	,	PUNCT
ajmpe-262	165	19	s.	s.	PROPN
ajmpe-262	165	20	a.	a.	PROPN
ajmpe-262	165	21	,	,	PUNCT
ajmpe-262	165	22	anaele	anaele	PROPN
ajmpe-262	165	23	,	,	PUNCT
ajmpe-262	165	24	o.	o.	PROPN
ajmpe-262	165	25	,	,	PUNCT
ajmpe-262	165	26	&	&	CCONJ
ajmpe-262	165	27	anthony	anthony	PROPN
ajmpe-262	165	28	,	,	PUNCT
ajmpe-262	165	29	t.	t.	PROPN
ajmpe-262	165	30	j.	j.	PROPN
ajmpe-262	165	31	(	(	PUNCT
ajmpe-262	165	32	2013	2013	NUM
ajmpe-262	165	33	)	)	PUNCT
ajmpe-262	165	34	.	.	PUNCT
ajmpe-262	166	1	studies	study	NOUN
ajmpe-262	166	2	on	on	ADP
ajmpe-262	166	3	prevalence	prevalence	NOUN
ajmpe-262	166	4	and	and	CCONJ
ajmpe-262	166	5	risk	risk	NOUN
ajmpe-262	166	6	factors	factor	NOUN
ajmpe-262	166	7	for	for	SCONJ
ajmpe-262	166	8	hepatitis	hepatitis	PROPN
ajmpe-262	166	9	b	b	PROPN
ajmpe-262	166	10	surface	surface	NOUN
ajmpe-262	166	11	antigen	antigen	ADV
ajmpe-262	166	12	among	among	ADP
ajmpe-262	166	13	secondary	secondary	ADJ
ajmpe-262	166	14	school	school	NOUN
ajmpe-262	166	15	students	student	NOUN
ajmpe-262	166	16	in	in	ADP
ajmpe-262	166	17	northcentral	northcentral	ADJ
ajmpe-262	166	18	,	,	PUNCT
ajmpe-262	166	19	nigeria	nigeria	PROPN
ajmpe-262	166	20	.	.	PUNCT
ajmpe-262	167	1	sierra	sierra	PROPN
ajmpe-262	167	2	leone	leone	PROPN
ajmpe-262	167	3	journal	journal	PROPN
ajmpe-262	167	4	of	of	ADP
ajmpe-262	167	5	biomedical	biomedical	ADJ
ajmpe-262	167	6	research	research	NOUN
ajmpe-262	167	7	,	,	PUNCT
ajmpe-262	167	8	5(1	5(1	NUM
ajmpe-262	167	9	)	)	PUNCT
ajmpe-262	167	10	,	,	PUNCT
ajmpe-262	167	11	5	5	NUM
ajmpe-262	167	12	-	-	SYM
ajmpe-262	167	13	12	12	NUM
ajmpe-262	167	14	.	.	PUNCT
ajmpe-262	168	1	oluboyo	oluboyo	PROPN
ajmpe-262	168	2	,	,	PUNCT
ajmpe-262	168	3	b.	b.	PROPN
ajmpe-262	168	4	o.	o.	PROPN
ajmpe-262	168	5	,	,	PUNCT
ajmpe-262	168	6	enitan	enitan	PROPN
ajmpe-262	168	7	,	,	PUNCT
ajmpe-262	168	8	s.	s.	PROPN
ajmpe-262	168	9	s.	s.	PROPN
ajmpe-262	168	10	,	,	PUNCT
ajmpe-262	168	11	adeleke	adeleke	ADJ
ajmpe-262	168	12	,	,	PUNCT
ajmpe-262	168	13	g.	g.	PROPN
ajmpe-262	168	14	,	,	PUNCT
ajmpe-262	168	15	&	&	CCONJ
ajmpe-262	168	16	oluboyo	oluboyo	NOUN
ajmpe-262	168	17	,	,	PUNCT
ajmpe-262	169	1	a.	a.	NOUN
ajmpe-262	169	2	o.	o.	PROPN
ajmpe-262	169	3	(	(	PUNCT
ajmpe-262	169	4	2014	2014	NUM
ajmpe-262	169	5	)	)	PUNCT
ajmpe-262	169	6	.	.	PUNCT
ajmpe-262	170	1	prevalence	prevalence	NOUN
ajmpe-262	170	2	of	of	ADP
ajmpe-262	170	3	hepatitis	hepatitis	PROPN
ajmpe-262	170	4	b	b	PROPN
ajmpe-262	170	5	and	and	CCONJ
ajmpe-262	170	6	c	c	PROPN
ajmpe-262	170	7	viral	viral	ADJ
ajmpe-262	170	8	infections	infection	NOUN
ajmpe-262	170	9	among	among	ADP
ajmpe-262	170	10	medical	medical	ADJ
ajmpe-262	170	11	students	student	NOUN
ajmpe-262	170	12	in	in	ADP
ajmpe-262	170	13	ekiti	ekiti	PROPN
ajmpe-262	170	14	state	state	PROPN
ajmpe-262	170	15	university	university	PROPN
ajmpe-262	170	16	,	,	PUNCT
ajmpe-262	170	17	ado	ado	NOUN
ajmpe-262	170	18	-	-	PUNCT
ajmpe-262	170	19	ekiti	ekiti	PROPN
ajmpe-262	170	20	,	,	PUNCT
ajmpe-262	170	21	nigeria	nigeria	PROPN
ajmpe-262	170	22	.	.	PUNCT
ajmpe-262	171	1	international	international	ADJ
ajmpe-262	171	2	journal	journal	PROPN
ajmpe-262	171	3	of	of	ADP
ajmpe-262	171	4	current	current	ADJ
ajmpe-262	171	5	microbiology	microbiology	NOUN
ajmpe-262	171	6	and	and	CCONJ
ajmpe-262	171	7	applied	apply	VERB
ajmpe-262	171	8	sciences	science	NOUN
ajmpe-262	171	9	,	,	PUNCT
ajmpe-262	171	10	3(10	3(10	NUM
ajmpe-262	171	11	)	)	PUNCT
ajmpe-262	171	12	,	,	PUNCT
ajmpe-262	171	13	834	834	NUM
ajmpe-262	171	14	-	-	SYM
ajmpe-262	171	15	845	845	NUM
ajmpe-262	171	16	.	.	PUNCT
ajmpe-262	172	1	ott	ott	PROPN
ajmpe-262	172	2	,	,	PUNCT
ajmpe-262	172	3	j.	j.	PROPN
ajmpe-262	172	4	j.	j.	PROPN
ajmpe-262	172	5	,	,	PUNCT
ajmpe-262	172	6	stevens	stevens	PROPN
ajmpe-262	172	7	,	,	PUNCT
ajmpe-262	172	8	g.	g.	PROPN
ajmpe-262	172	9	a.	a.	PROPN
ajmpe-262	172	10	,	,	PUNCT
ajmpe-262	172	11	groeger	groeger	NOUN
ajmpe-262	172	12	,	,	PUNCT
ajmpe-262	172	13	j.	j.	PROPN
ajmpe-262	172	14	,	,	PUNCT
ajmpe-262	172	15	&	&	CCONJ
ajmpe-262	172	16	wiersma	wiersma	PROPN
ajmpe-262	172	17	,	,	PUNCT
ajmpe-262	172	18	s.	s.	PROPN
ajmpe-262	172	19	t.	t.	PROPN
ajmpe-262	172	20	(	(	PUNCT
ajmpe-262	172	21	2012	2012	NUM
ajmpe-262	172	22	)	)	PUNCT
ajmpe-262	172	23	.	.	PUNCT
ajmpe-262	173	1	global	global	ADJ
ajmpe-262	173	2	epidemiology	epidemiology	NOUN
ajmpe-262	173	3	of	of	ADP
ajmpe-262	173	4	hepatitis	hepatitis	PROPN
ajmpe-262	173	5	b	b	PROPN
ajmpe-262	173	6	virus	virus	NOUN
ajmpe-262	173	7	infection	infection	NOUN
ajmpe-262	173	8	:	:	PUNCT
ajmpe-262	173	9	new	new	ADJ
ajmpe-262	173	10	estimates	estimate	NOUN
ajmpe-262	173	11	of	of	ADP
ajmpe-262	173	12	age	age	NOUN
ajmpe-262	173	13	-	-	PUNCT
ajmpe-262	173	14	specific	specific	ADJ
ajmpe-262	173	15	hbsag	hbsag	ADJ
ajmpe-262	173	16	seroprevalence	seroprevalence	NOUN
ajmpe-262	173	17	and	and	CCONJ
ajmpe-262	173	18	endemicity	endemicity	NOUN
ajmpe-262	173	19	.	.	PUNCT
ajmpe-262	174	1	vaccine	vaccine	NOUN
ajmpe-262	174	2	,	,	PUNCT
ajmpe-262	174	3	30(12	30(12	NUM
ajmpe-262	174	4	)	)	PUNCT
ajmpe-262	174	5	,	,	PUNCT
ajmpe-262	174	6	22122219	22122219	NUM
ajmpe-262	174	7	.	.	PUNCT
ajmpe-262	175	1	https://doi.org/10.1016/j.vaccine.2011.12.116	https://doi.org/10.1016/j.vaccine.2011.12.116	NUM
ajmpe-262	175	2	spearman	spearman	NOUN
ajmpe-262	175	3	,	,	PUNCT
ajmpe-262	175	4	c.	c.	PROPN
ajmpe-262	175	5	w.	w.	PROPN
ajmpe-262	175	6	,	,	PUNCT
ajmpe-262	175	7	afihene	afihene	NOUN
ajmpe-262	175	8	,	,	PUNCT
ajmpe-262	175	9	m.	m.	NOUN
ajmpe-262	175	10	,	,	PUNCT
ajmpe-262	175	11	ally	ally	NOUN
ajmpe-262	175	12	,	,	PUNCT
ajmpe-262	175	13	r.	r.	PROPN
ajmpe-262	175	14	,	,	PUNCT
ajmpe-262	175	15	apica	apica	PROPN
ajmpe-262	175	16	,	,	PUNCT
ajmpe-262	175	17	b.	b.	PROPN
ajmpe-262	175	18	,	,	PUNCT
ajmpe-262	175	19	awuku	awuku	PROPN
ajmpe-262	175	20	,	,	PUNCT
ajmpe-262	175	21	y.	y.	PROPN
ajmpe-262	175	22	,	,	PUNCT
ajmpe-262	175	23	cunha	cunha	NOUN
ajmpe-262	175	24	,	,	PUNCT
ajmpe-262	175	25	l.	l.	PROPN
ajmpe-262	175	26	,	,	PUNCT
ajmpe-262	175	27	dusheiko	dusheiko	NOUN
ajmpe-262	175	28	,	,	PUNCT
ajmpe-262	175	29	g.	g.	PROPN
ajmpe-262	175	30	,	,	PUNCT
ajmpe-262	175	31	gogela	gogela	PROPN
ajmpe-262	175	32	,	,	PUNCT
ajmpe-262	175	33	n.	n.	NOUN
ajmpe-262	175	34	,	,	PUNCT
ajmpe-262	175	35	kassianides	kassianide	NOUN
ajmpe-262	175	36	,	,	PUNCT
ajmpe-262	175	37	c.	c.	NOUN
ajmpe-262	175	38	,	,	PUNCT
ajmpe-262	175	39	kew	kew	PROPN
ajmpe-262	175	40	,	,	PUNCT
ajmpe-262	175	41	m.	m.	NOUN
ajmpe-262	175	42	,	,	PUNCT
ajmpe-262	175	43	lam	lam	PROPN
ajmpe-262	175	44	,	,	PUNCT
ajmpe-262	175	45	p.	p.	NOUN
ajmpe-262	175	46	,	,	PUNCT
ajmpe-262	175	47	lesi	lesi	PROPN
ajmpe-262	175	48	,	,	PUNCT
ajmpe-262	175	49	o.	o.	NOUN
ajmpe-262	175	50	,	,	PUNCT
ajmpe-262	175	51	lohouès	lohouès	NOUN
ajmpe-262	175	52	-	-	PUNCT
ajmpe-262	175	53	kouacou	kouacou	PROPN
ajmpe-262	175	54	,	,	PUNCT
ajmpe-262	175	55	m.	m.	NOUN
ajmpe-262	175	56	j.	j.	PROPN
ajmpe-262	175	57	,	,	PUNCT
ajmpe-262	175	58	mbaye	mbaye	NOUN
ajmpe-262	175	59	,	,	PUNCT
ajmpe-262	175	60	p.	p.	PROPN
ajmpe-262	175	61	s.	s.	PROPN
ajmpe-262	175	62	,	,	PUNCT
ajmpe-262	175	63	musabeyezu	musabeyezu	PROPN
ajmpe-262	175	64	,	,	PUNCT
ajmpe-262	175	65	e.	e.	PROPN
ajmpe-262	175	66	,	,	PUNCT
ajmpe-262	175	67	musau	musau	PROPN
ajmpe-262	175	68	,	,	PUNCT
ajmpe-262	175	69	b.	b.	PROPN
ajmpe-262	175	70	,	,	PUNCT
ajmpe-262	175	71	ojo	ojo	PROPN
ajmpe-262	175	72	,	,	PUNCT
ajmpe-262	175	73	o.	o.	PROPN
ajmpe-262	175	74	,	,	PUNCT
ajmpe-262	175	75	rwegasha	rwegasha	PROPN
ajmpe-262	175	76	,	,	PUNCT
ajmpe-262	175	77	j.	j.	PROPN
ajmpe-262	175	78	,	,	PUNCT
ajmpe-262	175	79	scholz	scholz	PROPN
ajmpe-262	175	80	,	,	PUNCT
ajmpe-262	175	81	b.	b.	PROPN
ajmpe-262	175	82	,	,	PUNCT
ajmpe-262	175	83	...	...	PUNCT
ajmpe-262	175	84	gastroenterology	gastroenterology	NOUN
ajmpe-262	175	85	and	and	CCONJ
ajmpe-262	175	86	hepatology	hepatology	NOUN
ajmpe-262	175	87	association	association	PROPN
ajmpe-262	175	88	of	of	ADP
ajmpe-262	175	89	subsaharan	subsaharan	PROPN
ajmpe-262	175	90	africa	africa	PROPN
ajmpe-262	175	91	(	(	PUNCT
ajmpe-262	175	92	ghassa	ghassa	NOUN
ajmpe-262	175	93	)	)	PUNCT
ajmpe-262	175	94	.	.	PUNCT
ajmpe-262	176	1	(	(	PUNCT
ajmpe-262	176	2	2017	2017	NUM
ajmpe-262	176	3	)	)	PUNCT
ajmpe-262	176	4	.	.	PUNCT
ajmpe-262	177	1	hepatitis	hepatitis	PROPN
ajmpe-262	177	2	b	b	PROPN
ajmpe-262	177	3	in	in	ADP
ajmpe-262	177	4	sub	sub	ADJ
ajmpe-262	177	5	-	-	ADJ
ajmpe-262	177	6	saharan	saharan	ADJ
ajmpe-262	177	7	africa	africa	PROPN
ajmpe-262	177	8	:	:	PUNCT
ajmpe-262	177	9	strategies	strategy	NOUN
ajmpe-262	177	10	to	to	PART
ajmpe-262	177	11	achieve	achieve	VERB
ajmpe-262	177	12	the	the	DET
ajmpe-262	177	13	2030	2030	NUM
ajmpe-262	177	14	elimination	elimination	NOUN
ajmpe-262	177	15	targets	target	NOUN
ajmpe-262	177	16	.	.	PUNCT
ajmpe-262	178	1	the	the	DET
ajmpe-262	178	2	lancet	lancet	PROPN
ajmpe-262	178	3	gastroenterology	gastroenterology	NOUN
ajmpe-262	178	4	&	&	CCONJ
ajmpe-262	178	5	hepatology	hepatology	NOUN
ajmpe-262	178	6	,	,	PUNCT
ajmpe-262	178	7	2(12	2(12	NUM
ajmpe-262	178	8	)	)	PUNCT
ajmpe-262	178	9	,	,	PUNCT
ajmpe-262	178	10	900	900	NUM
ajmpe-262	178	11	-	-	SYM
ajmpe-262	178	12	909	909	NUM
ajmpe-262	178	13	.	.	PUNCT
ajmpe-262	179	1	https://doi.org/10.1016/s2468-1253(17)30295-9	https://doi.org/10.1016/s2468-1253(17)30295-9	PROPN
ajmpe-262	179	2	trépo	trépo	PROPN
ajmpe-262	179	3	,	,	PUNCT
ajmpe-262	179	4	c.	c.	PROPN
ajmpe-262	179	5	,	,	PUNCT
ajmpe-262	179	6	chan	chan	PROPN
ajmpe-262	179	7	,	,	PUNCT
ajmpe-262	179	8	h.	h.	PROPN
ajmpe-262	179	9	l.	l.	PROPN
ajmpe-262	179	10	,	,	PUNCT
ajmpe-262	179	11	&	&	CCONJ
ajmpe-262	179	12	lok	lok	PROPN
ajmpe-262	179	13	,	,	PUNCT
ajmpe-262	179	14	a.	a.	NOUN
ajmpe-262	179	15	(	(	PUNCT
ajmpe-262	179	16	2014	2014	NUM
ajmpe-262	179	17	)	)	PUNCT
ajmpe-262	179	18	.	.	PUNCT
ajmpe-262	180	1	hepatitis	hepatitis	PROPN
ajmpe-262	180	2	b	b	PROPN
ajmpe-262	180	3	virus	virus	NOUN
ajmpe-262	180	4	infection	infection	NOUN
ajmpe-262	180	5	.	.	PUNCT
ajmpe-262	181	1	the	the	DET
ajmpe-262	181	2	lancet	lancet	PROPN
ajmpe-262	181	3	,	,	PUNCT
ajmpe-262	181	4	384(9959	384(9959	NUM
ajmpe-262	181	5	)	)	PUNCT
ajmpe-262	181	6	,	,	PUNCT
ajmpe-262	181	7	2053	2053	NUM
ajmpe-262	181	8	-	-	SYM
ajmpe-262	181	9	2063	2063	NUM
ajmpe-262	181	10	.	.	PUNCT
ajmpe-262	182	1	https://doi.org/10.1016/s0140-6736(14)60220-8	https://doi.org/10.1016/s0140-6736(14)60220-8	PROPN
ajmpe-262	182	2	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-262	182	3	https://doi.org/10.11604/pamj.2018.30.69.14579	https://doi.org/10.11604/pamj.2018.30.69.14579	X
ajmpe-262	182	4	https://doi.org/10.2217/fvl.13.11	https://doi.org/10.2217/fvl.13.11	CCONJ
ajmpe-262	182	5	https://doi.org/10.1016/s0140-6736(09)60207-5	https://doi.org/10.1016/s0140-6736(09)60207-5	PROPN
ajmpe-262	182	6	https://doi.org/10.4103/1119-3077.151035	https://doi.org/10.4103/1119-3077.151035	PROPN
ajmpe-262	182	7	https://doi.org/10.1016/j.vaccine.2011.12.116	https://doi.org/10.1016/j.vaccine.2011.12.116	NUM
ajmpe-262	182	8	https://doi.org/10.1016/s2468-1253(17)30295-9	https://doi.org/10.1016/s2468-1253(17)30295-9	PROPN
ajmpe-262	182	9	https://doi.org/10.1016/s0140-6736(14)60220-8	https://doi.org/10.1016/s0140-6736(14)60220-8	PROPN
ajmpe-262	182	10	american	american	PROPN
ajmpe-262	182	11	journal	journal	PROPN
ajmpe-262	182	12	of	of	ADP
ajmpe-262	182	13	medical	medical	ADJ
ajmpe-262	182	14	and	and	CCONJ
ajmpe-262	182	15	physical	physical	ADJ
ajmpe-262	182	16	education	education	NOUN
ajmpe-262	182	17	vol.10	vol.10	NOUN
ajmpe-262	182	18	,	,	PUNCT
ajmpe-262	182	19	issue	issue	NOUN
ajmpe-262	182	20	4	4	NUM
ajmpe-262	182	21	;	;	PUNCT
ajmpe-262	182	22	july	july	PROPN
ajmpe-262	182	23	-	-	PUNCT
ajmpe-262	182	24	august	august	PROPN
ajmpe-262	182	25	2025	2025	NUM
ajmpe-262	182	26	;	;	PUNCT
ajmpe-262	182	27	issn	issn	PROPN
ajmpe-262	182	28	:	:	PUNCT
ajmpe-262	182	29	2994	2994	NUM
ajmpe-262	182	30	-	-	SYM
ajmpe-262	182	31	0524	0524	NUM
ajmpe-262	182	32	impact	impact	NOUN
ajmpe-262	182	33	factor	factor	NOUN
ajmpe-262	182	34	:	:	PUNCT
ajmpe-262	182	35	7.06	7.06	NUM
ajmpe-262	182	36	1252	1252	NUM
ajmpe-262	182	37	columbia	columbia	PROPN
ajmpe-262	182	38	rd	rd	PROPN
ajmpe-262	182	39	nw	nw	PROPN
ajmpe-262	182	40	,	,	PUNCT
ajmpe-262	182	41	washington	washington	PROPN
ajmpe-262	182	42	dc	dc	PROPN
ajmpe-262	182	43	,	,	PUNCT
ajmpe-262	182	44	united	united	PROPN
ajmpe-262	182	45	states	states	PROPN
ajmpe-262	182	46	https://topjournals.org/index.php/	https://topjournals.org/index.php/	PROPN
ajmpe-262	183	1	ajmpe	ajmpe	NOUN
ajmpe-262	183	2	;	;	PUNCT
ajmpe-262	183	3	mail	mail	NOUN
ajmpe-262	183	4	:	:	PUNCT
ajmpe-262	183	5	topacademicjournals@gmail.com	topacademicjournals@gmail.com	X
ajmpe-262	183	6	7	7	NUM
ajmpe-262	184	1	|	|	ADV
ajmpe-262	184	2	a	a	DET
ajmpe-262	184	3	m	m	NOUN
ajmpe-262	184	4	e	e	NOUN
ajmpe-262	184	5	r	r	NOUN
ajmpe-262	184	6	i	i	NOUN
ajmpe-262	184	7	c	c	VERB
ajmpe-262	184	8	a	a	DET
ajmpe-262	184	9	n	n	NOUN
ajmpe-262	185	1	j	j	NOUN
ajmpe-262	185	2	o	o	X
ajmpe-262	185	3	u	u	NOUN
ajmpe-262	185	4	r	r	NOUN
ajmpe-262	185	5	n	n	NOUN
ajmpe-262	185	6	a	a	DET
ajmpe-262	185	7	l	l	NOUN
ajmpe-262	185	8	o	o	X
ajmpe-262	186	1	f	f	X
ajmpe-262	186	2	m	m	NOUN
ajmpe-262	186	3	e	e	NOUN
ajmpe-262	187	1	d	d	NOUN
ajmpe-262	187	2	i	i	PRON
ajmpe-262	187	3	c	c	VERB
ajmpe-262	187	4	a	a	DET
ajmpe-262	187	5	l	l	NOUN
ajmpe-262	187	6	a	a	X
ajmpe-262	187	7	n	n	NOUN
ajmpe-262	188	1	d	d	NOUN
ajmpe-262	188	2	p	p	NOUN
ajmpe-262	188	3	h	h	NOUN
ajmpe-262	188	4	y	y	NOUN
ajmpe-262	188	5	s	s	VERB
ajmpe-262	189	1	i	i	INTJ
ajmpe-262	189	2	c	c	VERB
ajmpe-262	189	3	a	a	DET
ajmpe-262	189	4	l	l	NOUN
ajmpe-262	189	5	e	e	NOUN
ajmpe-262	189	6	d	d	X
ajmpe-262	189	7	u	u	X
ajmpe-262	189	8	c	c	PROPN
ajmpe-262	190	1	a	a	DET
ajmpe-262	190	2	t	t	NOUN
ajmpe-262	191	1	i	i	PRON
ajmpe-262	191	2	o	o	VERB
ajmpe-262	192	1	n	n	CCONJ
ajmpe-262	192	2	|	|	ADV
ajmpe-262	192	3	https://topjournals.org/index.php/	https://topjournals.org/index.php/	INTJ
ajmpe-262	192	4	ajmpe	ajmpe	PROPN
ajmpe-262	192	5	world	world	PROPN
ajmpe-262	192	6	health	health	PROPN
ajmpe-262	192	7	organization	organization	PROPN
ajmpe-262	192	8	.	.	PUNCT
ajmpe-262	193	1	(	(	PUNCT
ajmpe-262	193	2	2022	2022	NUM
ajmpe-262	193	3	)	)	PUNCT
ajmpe-262	193	4	.	.	PUNCT
ajmpe-262	194	1	hepatitis	hepatitis	PROPN
ajmpe-262	194	2	b.	b.	PROPN
ajmpe-262	194	3	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b	X
ajmpe-262	194	4	mailto:topacademicjournals@gmail.com	mailto:topacademicjournals@gmail.com	PROPN
ajmpe-262	194	5	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b	https://www.who.int/news-room/fact-sheets/detail/hepatitis-b	X